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CHAPTER I
INTRODUCTION
Hereditary lysosomal S-glucosidase deficiency (Gaucher disease), an autosomal recessive disorder, is characterized by accumulation of the neutral glycosphingolipid glucosylceramide in the reticuloendothelial system--especially spleen, liver and the bone marrow (Brady

& Barranger, 1983).

This lipid abnormality arises due to a deficiency

of the specific catabolic lysosomal enzyme glucosylceramide:S-glucosidase (glucocerebrosidase) (Brady et al., 1965).
disease can be subclassified into three types:

Clinically, Gaucher

type 1 (adult non-

neuronopathic form), type 2 (infantile neuronopathic form) and type
3 (juvenile subacute neuronopathic form) (Desnick, 1982).
Although the lipid accumulated in the reticuloendothelial
system for all three types of Gaucher disease is glucosylceramide,
the lipid content in cultured human skin fibroblasts from subjects
with Gaucher disease is somewhat different.

In cultured fibroblasts,

there is not an increased amount of glucosylceramide, but there is a
higher quantity of the ganglioside sialosylgangliotriaosylceramide
(GMz) in type 2 Gaucher disease as compared to normal, and sialosylgangliotetraosylceramide (GM1), and disialosylgangliotetraosylceramide
(GD1a> in type 1 Gaucher disease (Saito & Rosenberg, 1984a,b).

At

this moment, however, it is not known if there are any other lipid
1

2
abnormalities in cultured human skin fibroblasts from Gaucher disease.
Since there is alteration of lipid composition in Gaucher
disease, it might be suspected that there may be alteration in membrane
fluidity of diseased fibroblast membranes.

This alteration in membrane

fluidity could possibly have a significant role in the pathogenesis
and pathology of Gaucher disease.

Therefore, it is important to under-

stand membrane structure in terms of membrane fluidity.
Fluidity specifically refers to properties of the hydrophobic
region of the membrane--in particular the physical state of the fatty
acyl chains comprising the bilayer structure (Stubbs & Smith, 1984).
Phenomena relevant to fluidity encompass unsaturation and acyl chain
length of fatty acids, lateral and rotational mobility of phospholipids, changes in the frequency of trans-gauche isomerization of
contiguous methylene groups (C-C bonds) in the phospholipid acyl
chains, changes in the swinging motion of the phospholipid fatty acyl
chains, changes in phospholipid headgroup conformation, changes in
interaction of cholesterol with other lipids, and changes in the interaction of proteins with lipids (Houslay & Stanley, 1982).
There are both chemical and physical effectors which can be

.

natural modulators of membrane lipid fluidity.

The main chemical

modulators are cholesterol content as compared with phospholipids,
the degree of unsaturation of phospholipid acyl chains, the content
of sphingomyelin as compared with phosphatidylcholine, and the content
of membrane proteins as compared with lipids.
of lipid fluidity are temperature,

The physical effectors

pressure, pH, membrane potential

and Ca2+ concentration (Shinitzky & Yuli, 1982).

3

There are several techniques for investigating fluidity of
biological membranes--including nuclear magnetic resonance (NMR),
electron spin resonance (ESR), and steady-state fluorescence polarization.

c-H

NMR is useful in determining motional characteristics of each

bond along the acyl chain.

disorder in membranes.

ESR gives information on degree of

Steady-state fluorescence polarization gives

information regarding overall motion of acyl chains adjacent to the
fluorescent probe (Stubbs & Smith, 1984).

Fluorescence polarization

has several advantages over ESR and NMR in that it can be readily
applied to complex systems such as biological membranes, the polarized signal is highly sensitive and reproducible, and the data obtained
are promptly interpretable.

It is to be noted, however, that the

common steady-state approach is an overall average of all membranes
involved and does not reflect only one aspect of the membranes (Shinitzky & Barenholz, 1978).
A considerable number of fluorescent probes are available for
fluidity measurements; however, l,6-diphenyl-1,3,5-hexatriene (DPH)
is the most efficient probe for investigating membrane fluidity of
biological systems.

DPH is a hydrophobic, rigid, elongated molecule

with cylindrical symmetry (Zannoni et al., 1983).

It aligns norm-

ally with its long axis parallel to the lipid chains in the middle
of the membrane bilayer (Lentz et al., 1976a,b).

It has no fluores-

cence signal when in an aqueous environment; however, when incorporated
into the lipid bilayer, it displays a sharp fluorescence signal
(Shinitzky & Barenholz, 1974).

It is to be noted, again, that DPH

can only give some average value of fluidity in the heterogenous lipid

4
domains present in cell membranes (Shinitzky & Barenholz, 1978).
Owing to its many useful and well-defined properties, DPH
has been used to evaluate membrane fluidity, via fluorescence polarization, of a variety of cell membranes.

In particular, it has been

used on cultured human skin fibroblasts from subjects with various
diseases with interesting results.

Using DPH as a probe in whole cells

or plasma membranes of familial hypercholesterolemia (Haggerty et
al., 1978), and Duchenne dystrophy plasma membranes (Shaw et al.,
1983), it has been shown that there is an increased fluidity of membranes as compared to matched controls; whereas, whole cells or plasma
membranes of cultured fibroblasts from Huntington's disease do not
exhibit any significant difference in membrane fluidity from controls
(Lakowicz

& Sheppard, 1981; Schroeder et al., 1984).

Even though

this technique of determining membrane fluidity has not been used
considerably in various diseases with membrane lipid abnormalities
in cultured human skin fibroblasts, it has a useful potential in investigating inherited metabolic disorders-- especially Gaucher disease.
It is known that glycosphingolipidsare altered in Gaucher
disease; however, since glycosphingolipids make up only approximately
3 percent of total cell membrane lipids (Dawson et al., 1972), they
possibly do not contribute significantly to the average membrane fluidity.

The major contributors to the lipid fluidity in membranes

seem to be cholesterol and phospholipids (Borochov et al., 1977; Cooper
et al., 1977, 1978; Shinitzky & Barenholz, 1978; Van Blitterswijk et
al., 1981).

It is not known at present whether the content of neutral

lipids and phospholipids are also altered along with glycosphingolipids

5

in cultured skin fibroblasts from subjects with Gaucher disease.
It is known that cholesterol and phospholipids may be altered
in red blood cells of patients with Gaucher disease (Balint et al.,
1963).

Along with this, there is evidence that phospholipid content

may be abnormal in Gaucher fibroblasts.

When glucosyl (3H) ceramide

(labeled in sphingosine as well as fatty acid moiety) was administered
to normal human fibroblasts, it was catabolized, and subsequently,
(3H) labeled products were found in phospholipids--especially sphingomyelin, phosphatidylcholine and phosphatidylethanolamine; whereas,
in Gaucher cells, this process is greatly reduced (Barton & Rosenberg
1974).
Any neutral lipid or phospholipid abnormality in Gaucher disease would imply that even though there is only a deficiency of one
enzyme, namely 8-glucocerebrosidase, leading to decreased catabolism
of glucosylceramide, the metabolic consequences are more widely felt,
affecting a variety of membrane lipids.

Such a finding has not been

reported and would be of great interest.
The objective of this dissertation is to evaluate the effect
of hereditary lysosomal S-glucosidase deficiency in cultured human
skin fibroblasts on membrane fluidity and correlate this with changes
in lipid composition.

Membrane fluidity in Gaucher disease and in

normal controls has been evaluated via the technique of steady-state
fluorescence anisotropy using the fluorescent hydrocarbon probe 1,6-diphenyl-1,3,5-hexatriene.

In addition, neutral lipid and phospholipid

composition of fibroblasts were evaluated and correlated with membrane
fluidity measurements.

Attention has been given to cholesterol,

6
sphingomyelin and phosphatidylcholine content of normal and diseased
fibroblasts and their fatty acid composition.

The amount of ceramide

has also been determined in normal and Gaucher diseased fibroblasts.
The effect of monensin on fibroblast lipids was also investigated
and correlated in terms of Gaucher disease lipid abnormalities.

CHAPTER II
REVIEW OF RELATED LITERATURE
Gaucher Disease
Clinical Disease
Gaucher disease is an autosomal recessive lysosomal disorder
characterized by deficiency of S-glucocerebrosidase activity with accumulation of neutral glycosphingolipid glucosylceramide in the reticuloendothelial system and possibly brain.

Clinically, Gaucher disease

can be classified into three major types as shown in Table 1 (Desnick
et al., 1982).

Type 1, chronic nonneuronopathic or "adult" form of

the disease is the most prevalent ( 1/2000 in United States Ashkenazi
Jews) among patients with Gaucher disease.

These patients usually

exhibit signs of hepatosplenomegaly along with symptoms of thrombocytopenia, anemia, and bone involvement.

Of the three types of the

disease, type 1 is probably least in degree of severity.

However,

in each individual patient, the severity of the disease varies greatly
along with the age of the individual (Brady & Barranger, 1983).
Type 2 Gaucher disease, also known as acute neuronopathic
or "infantile" form of the disease is the most severe in its presentation.

It is usually apparent before six months of age and fatal by

two years.

Not only is there massive hepatosplenomegaly but the

nervous system is heavily involved--exhibiting muscular hypertonicity

7

TABLE 1.--Gaucher Disease--Clinical Subtypes

Clinical Features

Type 1-NonNeuronopathic

Clinical onset

Childhood/adulthood

Type 2-Acute
Neuronopathic

Type 3-Subacute
Neuronopathic

Infancy

Childhood

Hepatosplenomegaly

+

+

+

Hematologic complications
Secondary to hypersplenism

+

+

+

Skeletal deterioration

+

+

+

Neurodegenerative course
Death
Ethnic predilection

+++
Variable
Ashkenazi Jewish

++

By 2 yr

2nd-4th decade

Panethnic

Swedish

Adapted from Desnick et al., (1982).

00
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and persistent retroflexion of the head.

This form of the disease

is not restricted to Jewish individuals but is pan-ethnic (Brady &
Barranger, 1983).
Type 3 Gaucher disease, also known as subacute neuronopathic
or "juvenile" form of the disease is also characterized by hepatosplenomegaly and neurologic involvement.

The neurologic damage, how-

ever, occurs later in life and is usually fatal (Brady & Barranger,
1983).

The ethnic predilection seems to be of non-Jewish individuals

involving Swedish people in particular Norbottnian

types (Svennerholm

et al. , 1982) •

Pathology and Pathogenesis
One of the pathognemonics for Gaucher disease is the presence
of Gaucher cells in the reticuloendothelial system.

These are large

macrophage like cells, having a "wrinkled tissue paper" appearance
(Brady & Barranger, 1983).

Along with the presence of Gaucher cells

in the reticuloendothelial system, there is a considerable hepatosplenomegaly encountered in this disease.

Along with this, there is

a frequent skeletal involvement in patients with types 1 and 3 Gaucher
disease.

In types 2 and 3 Gaucher disease, there is extensive neuro-

logic involvements.
involved.

The cranial nerves and brainstem are heavily

There is minimal storage of glucocerebroside in ganglion

cells, but there is loss of neurons, neuronophagia, and deposition
of this neutral glycolipid in periadventitial cells.
It seems logical to conclude that most of the pathology that
arises in Gaucher disease is due to an accumulation of glucosyiceramide
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in the reticuloendothelial system.

It seems, however, that there is

some accumulation of glucosylsphingosine in the brains of patients with
Gaucher disease leading to the acute severity of type 2 and type 3
disease (Nilsson & Svennerholm, 1982).

This then could be similar

to Krabbe's disease in which there is a deficiency of the enzyme
galactocerebroside:S-galactosidase leading to an increased amount of
galactosylceramide and the toxic galactosphingosine (Suzuki & Suzuki,
1983).

The involvement of glucosylsphingosine in the pathogenesis

of Gaucher disease is a very preliminary finding and would have to
be reconfirmed.
Diagnosis
There are several ways to arrive at the diagnosis of Gaucher
disease once it is suspected in a particular patient.

Not only is

there hepatosplenomegaly and Gaucher cells in the bone marrow aspirates
but there is elevation of serum nontartarate-inhibitable acid phosphatase.

The most sensitive method of establishing the diagnosis is

the measurement of the enzyme S-glucosidase in tissues obtained from
liver biopsies, cultured amniotic fluid cells, white blood cell preparations or cultured skin fibroblasts (Brady & Barranger, 1983).
There are various methodologies, utilizing various substrates
and activators, available to assay the activity of 8-glucosidase.
The two most widely used substrates are radioactively labeled glucosylceramide and the artificial fluorogenic substrate 4-methylumbelliferyl-S-glucoside.

The labeled glucosylceramide is the best method

for diagnosis of the disease; however, 4-methylumbelliferyl-S-glucoside
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is an inexpensive and efficient way to measure the S-glucosidase activity (Daniels & Glew, 1982).

There are several activators for this

enzyme which can be used in the assay of S-glucosidase activity--including negatively charged phospholipids, gangliosides, sodium taurocholate, Triton X-100, oleic acid and cutscum (Mueller & Rosenberg,
1977, 1979; Wenger & Olson, 1981; ; Saito et al., 1982; Vaccaro et
al., 1983).

It should be noted that there is reduced activity of

S-glucosidase in samples obtained from patients with Gaucher disease
as compared to matched controls.

Currently, there is no way to dis-

tinguish the clinical severity of the disease from the enzyme activity
data (Mueller & Rosenberg, 1979; Wenger & Olson, 1981).
Properties of S-Glucosidase
The reaction catalyzed by S-glucosidase for cleaving glucosylceramide into glucose and ceramide is as shown in Figure 1.

The

structural gene for S-glucosidase has been assigned to chromosome 1
using somatic cell hybridization techniques (Shafit-Zagardo et al.,
1981).

Using artificial substrate 4-methylumbelliferyl-S-D-glucoside,

two major S-glucosidases have been identified--"acid" and "neutral"
S-glucosidase (Shafit-Zagardo et al., 1980).

In cultured human skin

fibroblasts, there is only the "acid" form of S-glucosidase present
in the lysosomes.

Also, in the various Gaucher subtypes only the

acid isozyme is deficient in fibroblasts and other organs (Desnick,
1982).

This acid form of S-glucosidase is a lysosomal membrane-bound

enzyme or is very hydrophobic requiring detergents for optimum activity
(Mueller

& Rosenberg, 1979; Desnick, 1982; Desnick et al., 1982).
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Fig. 1. Schematic representation of hydrolysis of glucosylceramide into glucose and ceramide by S-Glucosidase. Adapted from
Desnick (1982).
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Using an antibody raised against placental glucocerebrosidase,
cultured skin fibroblasts have been identified to have two major
isozymes with molecular weights (Mr) of 63,000 and 56,000 and a minor
component with Mr of 61,000 (Ginns et al., 1982).

In type 1 Gaucher

disease, the major S-glucosidase isozyme exhibits Mr of 56,000 with
minor bands occurring at Mr of 63,000 and 61,000.

There is cross-

reacting material to Mr of 63,000 in type 3 disease; whereas, there
is no crossreacting material found in type 2 Gaucher fibroblasts (Ginns
et al., 1983).
There seems to be no difference in the pH optima, and Km values
of S-glucosidase in Gaucher fibroblasts (all three types) as compared
to normal cells.

However, the Vmax for S-glucosidase from Gaucher

fibroblasts is decreased as compared to normals (Desnick et al., 1982;
Saito et al., 1982).

Based on inhibitor and activator studies, the

active site of the enzyme has been proposed to have three components
(Gatt et al., 1982):
1.

Catalytic site--which recognizes S-glucosyl moiety of its
substrates and conduritol s-epoxide (an irreversible inhibitor of
the enzyme).

2.

Substrate binding site--which binds the aglycon moiety of
inhibitors and substrates.

3.

Hydrophobic site--which can bind lipids and other hydrophobic
molecules such as phosphatidylserine, glucosylsphingosine and
taurocholate.
Ho and O'Brien (1971) and Peters et al. (1977) have also iden-

tified a heat stable, soluble, acidic glycoprotein devoid of S-glu-
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cosidase activity as an activator protein for S-glucosidase.
Lipid Abnormalities
Glucosylceramide--consisting of sphingosine, a long-chain
fatty acid, and glucose--is considerably elevated in the reticuloendothelial system of patients with Gaucher disease.

The amount of

glucocerebroside in normal human spleens varies between 60-280 µg/gram
wet weight (Brady & Barranger, 1983). The values in Gaucher spleens
are considerably raised ranging from 3-40.S mg per gram wet weight.
Along with increased glucosylceramide, there are increased amounts of
GM3 but not lactosylceramide in the spleen (Kuske & Rosenberg, 1972).
The amount of glucosylceramide in brain of Gaucher disease patients
is somewhat variable.

In type 2 disease, there are increased amounts

of glucosylcermide in gray matter (Sudo, 1977); this lipid is also
increased in plasma in Gaucher disease (Vance et al., 1969).

However,

there may not be any increased amounts of glycolipids in brains from
types 1 and 3 patients.
The accumulated glucosylceramide in the reticuloendothelial
system arises from several sources.

Erythrocytes, which contain glu-

cosylceramide (GlcCer), lactosylceramide (LacCer), trihexosylceramide
and globoside, are catabolized via the reticuloendothelial system;
thereby, originating a source for GlcCer.

The turnover of leukocytes

is the major source of GlcCer along with LacCer (Suzuki, 1982).

Also,

it seems probable that this lipid could also arise from normal cellular
turnover (Brady & Barranger, 1983).
Unlike the accumulation of above mentioned lipids in the
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reticuloendothelial system, cultured human skin fibroblasts from
Gaucher disease have a different lipid accumulation as compared to
normal fibroblasts.

There is a higher quantity of the ganglioside

sialosylgangliotriaosylceramide (GM2) in type 2 Gaucher disease as
compared to normal, and sialosylgangliotetraosylceramide (GM1) and
disialosylgangliotetraosylceramide (GD1a> in type 1 Gaucher disease
(Saito & Rosenberg, 1984a,b).

Along with this, there is evidence that

phospholipid content may be abnormal in Gaucher fibroblasts.

When

glucosyl (3H) ceramide (labeled in sphingosine as well as fatty acid
moiety) was administered to normal human fibroblasts, it was catabolized, and subsequently, (3H) labeled products were found in phospholipids--especially sphingomyelin, phosphatidylcholine and phosphatidylethanolamine; whereas, in Gaucher cells, this process was
greatly reduced (Barton & Rosenberg, 1974).

Cholesterol levels in a

Gaucher fibroblast cell line has been determined and there seems to
be no difference as compared with normal cells (Warren et al., 1976).
There also seems to be an indication that erythrocyte neutral
lipid and phospholipids may be altered in Gaucher disease.

Balint

et al. (1963) have shown that there is probably a decreased amount
of cholestrol, cephalins (PS & PE), and sphingomyelin in an adult
patient with Gaucher disease as compared to normal adult erythrocyte
lipids.
Treatment
Recently, a bone-marrow transplant was performed in a patient
with type 3 Gaucher disease with no change in clinical status post-
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transplantation.

The plasma glucocerebroside concentration, however,

returned to normal implying that the enzymatic abnormality in hematopaietic cells in Gaucher disease may be correctable by bone-marrow
transplantation (Rappeport

& Ginns, 1984).

Several trials of enzyme replacement via placental S-glucosidase infusion have also been tried but to no avail since the enzyme
was not taken up by the appropriate macrophage.

Thus, the only treat-

ment available for Gaucher disease is in the form of supportive treatment (Brady

& Barranger, 1983).
Membrane Fluidity

Concept of Membrane Fluidity
Fluidity specifically refers to the physical state or dynamics
of the fatty acyl chains comprising the membrane bilayer (Chapman,
1983; Stubbs

& Smith, 1983).

Phenomena relevant to fluidity encompass

unsaturation and acyl chain length of fatty acids, lateral and rotational mobility of phospholipids, changes in the frequency of transgauche isomerization of C-C bonds of methylene groups in the phospholipid acyl chains, changes in the swinging motion of the phospholipid
fatty acyl chains, changes in phospholipid headgroup conformation,
changes in interaction of cholesterol with membrane lipids, and changes
in the

intera~tion

1978; Houslay

of proteins with lipids (Shinitzky

& Barenholz,

& Stanley, 1982; Chapman, 1983; Stubbs & Smith, 1983).

The extent of unsaturation and chain length of fatty acids
is an important determinant of biomembrane fluidity.

The exact cor-

relation with membrane fluidity to the unsaturation and fatty acyl
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chain length seems varied and complex depending on the number, position, and type of the double bonds, the nature of membrane under investigation and the method used to probe the membrane physical state
(Stubbs, 1983).

Using model membranes it has been concluded that

the effect of increasing the unsaturation results in only a slight
increase in acyl chain mobility (Stubbs & Smith, 1984).

A decrease

in double bond index/saturated fatty acid ratio, defined as:
(number unsaturated mol x no. double bonds)
(number saturated mol)
has been used as a chemical measure of membrane fluidity (Farias et
al., 1975).

This assumption is valid when other parameters such as

cholesterol/phospholipid ratio remain constant and the fatty acid
double bonds of compared membranes have the same cis structure (Castuma

& Brenner, 1983).

Studies with biological membranes show that a sig-

nif cant change in level of unsaturation and chain length does not
necessarily lead to changes in fluidity as measured with

fluorescent

or ESR probes (Gilmore et al., 1979a,b; Herring et al., 1980; Stubbs
et al., 1980; Stubbs & Smith, 1984).
Various head groups, lateral and rotational mobility, transgauche isomerization, and fatty acyl chain swinging motions of phospholipids are relevant to membrane fluidity.

Similar to the data

for unsaturation and fatty acyl chain length mentioned previously,
the influence of the phospholipid head groups on the motion of the acyl
chain (and thus fluidity) in cell membranes is complex and varied
(Gilmore et al., 1976b; Stubbs, 1983).

Although it is clear that

the head group region has an influence on acyl chain motion, it is
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difficult to assess its importance in biological membranes due to
the fact that the phospholipids in membranes have differing fatty
acid composition (Stubbs, 1983).

With respect to the lateral and

rotational mobility, trans-gauche isomerization and fatty acyl chain
swinging motions of phospholipids, it is known that they all can influence the membrane fluidity; however, the fluorescence method utilized in this dissertation cannot discern the effects of these parameters (Stubbs, 1983; Stubbs & Smith, 1984).
Cholesterol is a principal modulator of membrane fluidity.
This lipid has rigid, planar, wedge-shaped structure which orients
perpendicular to the membrane bilayer, with the hydroxyl group in
the vicinity of the fatty acyl carbonyls, as shown in Figure 2 (Houslay

& Stanley, 1982; Stubbs, 1983).

Cholesterol has the ability to con-

dense phospholipid bilayers (Kitajima & Thompson, 1977).

A variety

of physical techniques have demonstrated that cholesterol has a small
fluidizing effect below the phase transition temperature (gel phase)
of phospholipids and a large rigidizing effect above this temperature
(Oldfield & Chapman, 1972; Kawato et al., 1978; Chapman, 1983).
Presence of large amounts of cholesterol prevents lipid chain crystallization and removes phase transition characteristics (Chapman, 1983).
In general, therefore, the effect of cholesterol in biological membranes is to decrease fluidity (Kawato et al., 1978; Hildenbrand &
Nicolau, 1979).

The cholesterol/phospholipid ratio has been used to

represent the amount of order (rigidity, inverse of fluidity) in membranes (Shinitzky & Barenholz, 1978; Van Blitterswijk et al., 1981;
Houslay

& Stanley, 1982).
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Fig. 2. Schematic representation of a cholesterol molecule
with a phospholipid in a lipid bilayer. Adapted from Houslay and
Stanley (1982).
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Proteins also have translational and rotational movements in
the membrane.

This has been investigated on the bacterial protein

rhodopsin; where it was shown by electron spin resonance that proteins
have

specific rotational diffusion rates (Barrion et al., 1977) and,

by fluorescence photobleaching recovery, that proteins have a specific
lateral diffusion rates as well.

The estimation of the contribution

of membrane proteins to membrane fluidity depends on the type of membrane involved and the method used to determine membrane fluidity.
In contrast to electron spin resonance and fluorescence photobleaching
recovery, steady-state fluorescence anisotropy of proteins using the
probe diphenylhexatriene gives virtually no contribution to fluidity
in lymphoid, liver, hepatoma, and erythrocyte membranes (Van Blitterswijk et al., 1981).
Along with nature of fatty acyl composition, cholesterol,
phospholipid structures, and proteins there are various physical effectors of lipid fluidity including pressure, pH, membrane potential,
Ca2+ concentration and temperature (Shinitzky & Yuli, 1982).

Of these,

temperature plays an important role in membrane fluidity; and it can
be generally stated that fluidity increases with increasing temperature
and this corresponds to an overall increase in molecular motion
throughout the membrane bilayer.
With respect to the effect of temperature on membrane fluidity,
one can observe various phases of lipids as the temperature is varied
in biological membranes (phase transition).

This phase transition

occurs at characteristic temperatures for a particular phospholipid
species.

Phase transition detects lipid phase separations in the
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biological membranes, where lipid phase separation can be defined as
spontaneous coexistence of membrane domains with different composition
(Grant, 1983).

The two phases for phospholipids are:

crystalline-

solid state where the acyl chains of phospholipid are fully extended
parallel to the bilayer with their C-C bonds in the all-trans position,
and liquid-crystalline (fluid) state in which there are rotational
isomers about the C-C bonds of the fatty acyl chains (Houslay &
Stanley, 1982).
At the lipid phase transition temperature the bilayer changes
from solid to the fluid state.

The nature of the headgroup, the length

of the fatty acyl chain, and the number, position and type of double
bonds in the acyl chain of a phospholipid determine its phase transition temperature (Houslay & Stanley, 1982; Chapman, 1983).

It should

also be noted, however, that since cholesterol increases the rigidity
of fluid-state lipid bilayers and increases the fluidity of solidstate lipid bilayers, it may tend to cancel or dampen the lipid phase
transition in biological membranes (Oldfield & Chapman, 1972; Houslay

& Stanley, 1982; Chapman, 1983).

As a theoretical consideration,

the evidence for lateral phase separation comes from studies showing
non-linear Arrhenius plots of the temperature dependence of fluorescence anisotropy (Shinitzky & Yuli, 1982; Stubbs, 1983).
Techniques for Determining
Membrane Fluidity

NMR
Nuclear magnetic resonance (NMR) studies of membrane structure
employ the (2H) NMR method with high field superconducting magnets to
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investigate the organization of polar headgroups and backbone and
hydrocarbon chain regions in phospholipids and glycolipids (Smith &
Oldfield, 1984).

With the deuterated species of interest incorporated

into the membrane, motional characteristics of C-H bond can be determined by this technique.

From this, it has been possible to obtain

an order profile for phospholipid acyl chains (Seelig & Seelig, 1977).
The drawback of performing NMR studies is the expensive apparatus
required and the need to synthesize specially deuterated lipids in
relatively large amounts.

Also the calculations and assumptions in

deriving the rate of motion are very complex and may be less reliable
than those obtained in fluorescence studies (Stubbs, 1983).
ESR
Electron spin resonance of a nitroxide probe in the membrane
bilayer can give information on relaxation (mobility) of the probe,
orientation of the probe with respect to its environment, concentration
of the label in a given phase, order of the system, and the lateral
diffusion of the probe in the plane of the bilayer (Jain & Wagner,
1980).

Much of the information on membrane structure has arisen from

ESR studies.

The theory behind ESR is similar to that of NMR and has

been reviewed extensively elsewhere (Cantor

& Schimmel, 1980).

One

of the major drawbacks for .this technique is similar to that of NMR
in which the equipment is expensive.

Also, one needs to synthesize

spin-labeled probes,and the probe perturbs the system.
Raman Spectroscopy
Raman spectroscopy is a relatively new technique for deter-
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mining acyl chain motions in membranes by looking at the vibrational
states of C-C bonds.

Even though it is a non-perturbing technique

which has provided information on model lipid bilayers, interference
from bonds in the phosphate and protein regions occurs with biological
membranes (Stubbs, 1983).

It is still in its infancy stages and much

more experimentation is needed in order for this to be a major tool
in membrane fluidity investigations of biological membranes.
Fluorescence Spectroscopy
Fluorescence spectroscopy is based on the phenomenon that
when a fluorophore is excited by light, the fluorophore absorbs the
energy and emits photons of lower energy.

This phenomenon then can

be adapted to give information on the orientation or range and rate
of motion of the fluorophore and its adjacent environment.

There

are several fluorescence techniques which give information on lipid
rotational motion including fluorescence photobleaching recovery and
fluorescence anisotropy.
In fluorescence photobleaching recovery, membrane lipids are
labeled with a fluorescent compound and a small area of labeled cell
is exposed to a laser pulse.

The time dependence of fluorescence

recovery in the bleached area is followed over time and from it lateral
diffusion constants can be obtained (Golan et al., 1983; Stubbs,
1983).

This has been used to determine lateral diffusion of proteins

as well as lipids and the way lipid-protein interaction may occur
(Golan et al., 1984; Spiegel et al., 1984).
Fluorescence anisotropy techniques can include both time-
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resolved decay and steady-state anisotropy measurements.

Time-resolved

fluorescence anisotropy decay gives information on the range of acyl
motion and the rate of motion.

Investigators using the fluorescent

probe DPH, a rod shaped molecule which aligns parallel to the acyl
chains in the middle of the membrane bilayer, have assumed the range
of acyl chain motion to be contained within a volume approximating
to a cone which has an half angle (8c) (Kawato et al., 1977; Kinosita
et al., 1977; Kawato
model.

et al., 1978)--also known as "wobbling-in-cone"

From the half angle, one can determine the order parameter

(S):
S

= [1/2

cos 8c (1 + cos 8c)J2.

The rate of probe motion is described as the wobbling diffusion constant CDw), which is obtained from the apparent rotational relaxation
time (¢):

Dw

= o/¢,

where a has been experimentally determined (Kawato

et al., 1978; Stubbs et al., 1984).
Steady-state fluorescence anisotropy gives information on
rate of rotational diffusion of the probe as well as range of motion
of the probe (Van Blitterswijk et al., 1981; Stubbs & Smith, 1984).
Steady-state fluorescence measurements give information on the microviscosity as well as the order parameter in relation to decay measurements--to be discussed in the next section in considerable detail.
Fluidity parameters of lipids in biomembranes are usually determined
via this method and the information obtained is an overall average
of all lipid domains present in cell membranes.

Fluorescence ani-

sotropy measurements have several advantages over ESR and NMR in that
it can be readily applied to complex systems such as biological mem-
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branes, the polarized signal is highly sensitive and reproducible,
and the data obtained are promptly interpretable (Shinitzky & Barenholz, 1978).

Whereas, fluorescence anisotropy decay measurements

take longer and require complex apparatus and analysis (Stubbs, 1983).

Steady-State Fluorescence Anisotropy
Theory
When a fluorophore is incorporated into biomembranes and it
is excited by a continuous source of plane polarized light (along
z-axis in figure 3), the steady state fluorescence anisotropy (rs)
and polarization (p) can be determined by the emission intensities
through an analyzer oriented parallel ( I 11 ) and perpendicular (IJ_)
to the direction of polarization of the excitation light.

Generally,

the emission is detected at a right angle to the excitation, and the
direction of polarization of I 11 is along z-axis and IJ_ is along y-axis
in the figure.

From this, the values for fluorescence polarization

and anisotropy can be calculated as:
p = II I - IJ.

(1)

Ill + IJ.

rs =

I11
I11

- Il.

2P

+ 2IJ.

3 - p

where the range of P is -1/3<P<l/2 and rs is -1/5<rs<2/5.

(2),

The total

fluorescence intensity (F) can be calculated as:
F

= I1 I

+ 2Il.

(3).

From the steady-state fluorescence anisotropy determinations of the
membrane in question, there are two ways to evaluate and interpret
membrane fluidity.

One interpretation is that the anisotropy reflects
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Fig. 3. Schematic representation of various parameters
utilized in fluorescence polarization. Adapted from Cantor and
Schimmel (1980).
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the rate of rotational diffusion of the probe, or microviscosity.

Note

that the average fluidity of the membranes can then be calculated as
the reciprocal of the apparent microviscosity {n).

The apparent micro-

viscosity of the membrane interior is estimated by comparing the fluorescence anisotropy in the system with that observed in a macroscopicisotropic system {reference mineral oil) and applying the classical
hydrodynamic system of Perrin to yield the Perrin equation:

n = c (r

s

)

TT{:_o -1)-l
rs

{ 4) •

where C(r ) is a parameter which relates to the molecular shape and
s
the location of the transition dipoles of the fluorophore as expressed
in the determined anisotropy {rs) values, T is the absolute temperature, T is the excited state lifetime of the probe, and r 0 is the
limiting value of rs at infinite viscosity.

The units for n is dyne-

s-cm-2 which is defined as 1 P {poise) {Shinitzky & Barenholz, 1978).
The values for C(r )' r 0 and T can be determined
s
for the individual probe in question. However, the values for DPH,
a widely used and efficient probe, have been determined to yield r 0

= 0.362

and C

(r)

TT remains relatively constant in liposomes and model

membranes yielding a value of 2.4 poise for temperatures between 0-40°C
{Shinitzky & Barenholz, 1978).

From this, an approximate value of

n

can be calculated for DPH in membranes to yield:

n =

0.362 - rs

= 0.462P-

p

(5).

It can be seen from this modified empirical Perrin equation that as
the value of anisotropy increases, the apparent microviscosity increases and, thus, the fluidity decreases.
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From the microviscosity, phase transitions and thus phase
separation in lipids can be determined by the Arrhenius plot of log

n versus

1/ T.

If there are any phase separations of lipid domains,

the Arrhenius plot will be non-linear; whereas, if there is a straight
line in the Arrhenius plot, it implies that there are no phase transitions of the lipid under investigation and thus the steady-state fluorescence polarization technique cannot detect phase separations of
lipid domains (Shinitzky & Barenholz, 1978).
One of the major assumptions in the Perrin type calculations
for apparent microviscosity is that the probe is localized in an isotropic medium; whereas, membranes have an anisotropic environment.
Although the apparent microviscosity calculated may not be absolute,
it is useful in comparing membrane fluidities.

The second interpreta-

tion of the steady-state fluorescence anisotropy data comes from timeresolved fluorescence polarization decay measurements.

From this,

it was interpreted that it is mainly the degree to which the fluorophore rotations are restricted by the molecular packing of the lipids
(a static factor), rather than its rotational rate (a dynamic factor),
which determines the steady-state fluorescence anisotropy in lipid
membranes.

Thus, rs can be resolved into a static part r 00 (propor-

tional to the square of lipid order parameter), and a dynamic parameter
rf (related to the rotational relaxation time of the fluorophore--which
in turn is proportional to the microviscosity) (Van Blitterswijk et
al., 1981; Pottel et al., 1983).
rs= rf + roo

As an equation,
(6).

Also, for the probe DPH, the limiting fluorescence anisotropy, r 00 ,
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is proportional to the square of the lipid order parameter, S
O<S<l
where r 0 is the fluorescence anisotropy value in

(7)
th~

absence of a

rotational motion of the probe and is 0.362 for DPH in biological membranes.
From experimental data for the steady state fluorescence anisotropy (rs) and the limiting fluorescence anisotropy (r 00 ) of a variety
of artificial and biological membranes, an empirical relationship can
be arrived:
(8)

in the region 0.13 < rs <0.28--which is the value for most biological
membranes.

From equations 7 and 8, the order parameter can be calcu-

lated

4

Sopff

= C-3

1/2
rs_ 0.28 )
ro

( 9) •

As can be seen from equation (9), as the anisotropy increases, so
does the order parameter.
It is believed by Van Blitterswijk et al. (1981) that the
structural order of membrane lipids is related to the degree of molecular packing.

Lipid fluidity may then be defined as the reciprocal

of the lipid structural order parameter (Sopff) rather than apparent
microviscosity.

The physical state of the biological membrane can thus

be suitably described by the order parameter (Pottel et al., 1983).
In this theory, also, lateral phase separation can be determined by
the non-linear Arrhenius plots of the steady-state fluorescence anisotropy versus the temperature (Stubbs, 1983).
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Although the apparent microviscosity is not in an absolute
scale and the lipid order parameter (Sopff) only takes into account
the static component of rs, both of these parameters can be considered
to define the inverse of lipid fluidity.

It is not certain at this

point which interpretation of steady-state fluorescence anisotropy
data is appropriate; however, they both imply that an increase in
steady-state anisotropy value of the membrane is due to a decrease
in membrane fluidity (Castuma & Brenner, 1983).
Fluidity Probes
There are several probes utilized in studying membrane fluidity.

Of the many examples, fluorescent probes can be divided into

two major classes.

The first class includes fluorescent compounds

which can incorporate spontaneously into a well defined lipid region
of membranes--thus, directly reflecting the membrane fluidity from
its fluorescence anisotropy values.

The other class includes flu-

orescent dyes which are covalently attached to fatty acids or phospholipids (Shinitzky & Barenholz, 1978).

Examples of the first class

include l,6-diphenyl-1,3,5-hexatriene (DPH) and perylene; whereas,
examples of the latter class include parinaric acid and its phospholipid derivatives,l-acyl-2-N-4-nitrobenzeno-2-oxa-1,3-diazole-aminocaproyl phospholipid (NBD-phospholipid), and DL-12-(9-anthroyl) stearic
acid.

In the context of membrane fluidity, the most efficient probes

are perylene and DPH and thus shall be discussed in some detail.
Perylene
Perylene is a flat aromatic molecule with an approximate shape
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of a disk with a diameter of 0.8 nm, as shown in Figure 4 (Zannoni
et al., 1983).

The absorption and emission spectrum of perylene over-

lap somewhat and exhibit a good mirror symmetry.

It is a stable flu-

orophore with a considerably shorter fluorescence decay time of 'o
7.2ns; whereas •o for DPH

= 11.4

ns.

=

Also, the excited state lifetime

of perylene is much more sensitive to temperature or fluidity changes
--thus, this probe is used similar to DPH in high fluidity systems
(Shinitzky & Barenholz, 1978).
DPH
DPH is one of the most useful and efficient probes for studying
membrane fluidity.

It is a rigid, rod shaped molecule, approximately

1.3 nm long, with cylindrical symmetry, as shown in Fig. 5 (Zannoni
et al., 1983).

DPH absorbs light in near uv and emits with very high

quantum yield in the blue region of visible spectrum.

The absorption

spectrum of DPH in various organic solvents is shown in Figure 6.
It can be noted that the absorption spectrum changes as the polarity
of the solvent changes.

The absorption maximum occurs around 355 nm

with an extinction coefficient of 80,000 M-lcm-1 (Shinitzky & Barenholz, 1978).

In contrast to the absorption spectrum, the emission

spectrum of DPH changes very little with a change in solvent.

Particu-

larly, the emission maximum is relatively insensitive to changes in
polarity, viscosity and temperature (Zannoni et al., 1983).

The ab-

sorption and emission spectra do not show a good "mirror symmetry."
This probe in membranes has a high and constant value of r 0 of 0.362
and a fluorescence decay time of •o

= 11.4

ns.
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Fig. 4. (a) The molecular structure of perylene. (b) The
disk-like shape assumed for perylene. Adapted from Zannoni et al.
(1983).
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Fig. 5. The molecular structure of DPH with the rod-like
Adapted from Zannoni et al. (1983).
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Fig. 6. The absorption and fluorescence spectrum of DPH in
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Also shown is the polarization of fluorescence as a function of wavelength determined in polypropylene glycol at T = -50°C. Adapted from
Zannoni et al. (1983).
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There are certain favorable properties of DPH which allow it
to be an excellent membrane fluidity probe.

It has no fluorescence

signal when in an aqueous environment; however, when incorporated
into the lipid bilayer, it displays a sharp fluorescence signal
(Shinitzky & Barenholz, 1974, 1978).

Its high extinction coefficient

and fluorescence quantum yield allow the detection of a fluorescence
signal even at very low concentration (approximately lµM).

The sepa-

rated absorption and emission reduce the possibility of energy transfer
between DPH molecules and facilitate the elimination of excitation
light scattering.

The rod like shape aligns itself normally with

the long axis parallel to the lipid chains (Lentz et al., 1976a,b).
One of the more debated questions regarding the probe DPH is
its location in the membrane bilayer.

Owing to its property that

DPH in bilayers is similar to that in apolar organic solvents, and
it is relatively insoluble in water implies that DPH is located in
the hydrocarbon region of the bilayer.

The orientation of the long

axis of DPH is believed to be parallel

to that of the lipid chains

(Lentz et al., 1976a,b; Thulburn, 1981; Zannoni et al., 1983).

Once

DPH has been incorporated into the bilayer, it partitions equally well
into fluid or solid lipid domains (Lentz et al., 1976a,b).

The derived

fluidity represents the weight average of all lipid domains (Shinitzky

& Barenholz, 1978).
DPH in Biological Membranes
DPH has been extensively used as a probe in model membranes
such as liposomes and micelles as well as biological membranes.

With
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respect to the biological membranes, DPH has been used both in isolated
cell membranes and in intact cells.

When DPH is introduced into vari-

ous membrane lipids of intact cells, the dye is dissolved in the surface membrane lipid·layer within minutes (Shinitzky
1978).

& Barenholz,

The fluorescence of the labeled cells is initially confined

to the plasma membrane; however, with time the probe molecules partition into the cell inner membranes until an equilibrium distribution
is reached.

Pagano et al.

(1977) have shown using autoradiographic

methods that DPH, when incubated with intact fibroblasts locates itself
not only on the cell surface membrane but also in the cytoplasmic
regions.

It should be noted, however, in this method the labeled

cells are treated with cross-linking agents and ethanol, and the exposure time is days or weeks.

The conditions are non-physiological

and thus may increase the rate of partitioning of the probe.

Also,

Bouchy et al. (1981) have analyzed the evolution of DPH fluorescence
polarization following incubation in living cells.
crease of rs and
plasma membranes.

r~

They found a de-

with time, a decrease not present in isolated
This is also questionable since Haggerty et al.

(1977) found no difference between plasma membrane and cell microviscosity using fibroblasts.

However, it is important to note that

the fluidity of the whole cell gives physiologically important information which may be used in comparing disease states with normal controls.

One can also determine the lipid fluidity in plasma membranes

of intact cells by selective quenching (Grunberger et al., 1982).
As stated previously, the steady-state fluorescence anisotropy
using DPH has been measured in diseased states and there are several

r
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lipid abnormalities which correlate with an altered anisotropy values.
It is known that the cholesterol/phospholipid ratio is related to the
inverse of fluidity.

In red cells of patients with liver disease,

the cholesterol/phospholipid (mol/mol) ratio is increased to 1.0-1.6
from normal values of 0.9-1.0 with the concomitant decrease in membrane
fluidity in the diseased state (Cooper et al., 1972, 1978; Owen et al.,
1982).

As another example, the cholesterol/phospholipid ratio is

decreased in mouse thymus derived ascitic leukemic (GRSL) cells as
compared to normal thymocytes (GRSL
0.37).

= 0.22-0.30,

normal thymocyte

=

This is correlated with the increased fluidity observed in

the GRSL cells <nGRSL
et al., 1977).

= 1.73P,n

thymocyte

= 3.24P)

(Van Blitterswijk

Also, the cholesterol/phospholipid ratio is signif-

icantly elevated (0.52 + 0.045 versus 0.129 + 0.012) in cord mononuclear leukocytes as compared to adult cells and this is again correlated with increased microviscosity values (polarization values of
0.339 + 0.030 versus 0.186 + 0.019) (Neufeld & Carbo, 1984).
Another factor important in fluorescence anisotropy values
is the sphingomyelin to phosphatidylcholine ratio.

There is an in-

crease in the phosphatidylcholine/sphingomyelin (mol/mol) ratio in
sheep red blood cells treated with EGTA as compared to non-treated
red blood cells (0.14 :t_0.01 versus 0.030 :t_0.005); this increase in
phosphatidylcholine/sphingomyelin ratio is concomitant with an increase
in lipid fluidity ((r 0 /rs - 1)-l values at 25°C of 2.22 + 0.004 versus
2.58 + 0.004).

In this study, however, there was no increase in the

ratio of cholesterol/phospholipid noted (Borochov et al., 1977).
Also, the microviscosity of erythrocyte membranes from patients with
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abetalipoproteinemia was increased compared to normal erythrocytes
(nacanthocyte

= 4.01

- 4.14, nnormal

= 3.2

+ O.lP) which then is ex-

plained in terms of an excess amount of sphingomyelin in acanthocyte
membranes with a concomitant increase in the sphingomyelin/phosphatidylcholine ratio (0.84 :t_ 0.08 in normals, 1.45-1.61 in acanthocytes)
(Cooper et al.,1977).

Van Blitterswijk et al. (1981) have also stated

that sphingomyelin/total phospholipid ratio is an important determinant
in fluidity of membranes.

They show that for certain membranes, cho-

lesterol/phospholipid ratios remain constant but there is an altered
structural order parameter; and this could be due to an altered
sphingomyelin/phospholipid ratio.

The authors stipulate that the

sphingomyelin/phospholipid ratio is directly proportional to the order
parameter (and thus inversely to fluidity).
It is interesting to note that cholesterol/sphingomyelin ratio
may also be important since it has been theoretically proposed that
cholesterol tightly associates with sphingomyelin (Patton, 1970).
The existence of a strong preferential interaction between cholesterol
and sphingomyelin has been proven in artificial membranes (Barenholz

& Thompson, 1980).

At this moment, the exact ratio of cholesterol/

sphingomyelin has not been correlated with any fluidity change, but
the literature does point to it (Barenholz et al., 1981; Barenholz &
Thompson, 1980; Van Blitterswijk et al., 1981).
When cholesterol/phospholipid ratio and sphingomyelin/ phosphatidylcholine ratio are constant but there is an altered membrane
fluidity, the double bond index/saturated fatty acid ratio can be
correlated with the changes in fluidity.

A decrease in this ratio
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leads one to conclude that there might be a decrease in lipid bilayer
fluidity (Farias et al., 1975).

As an example, this has been done

with livermicrosomal membranes from guinea-pigs on a fat-free diet
in which there was a decrease in membrane fluidity with no change in
cholesterol/phospholipid ratio.

However, there was a decrease in

the double bond index/saturated fatty acid ratio corresponding to the
decreased membrane fluidity.
It is known that certain organisms can adapt to changes in
their environmental temperature by altering their lipid composition
and a constant lipid fluidity is maintained--termed homeoviscous adaptation.

Cultured cells have a limited ability to exhibit the property

of homeoviscous adaptation.

A transformed murine fibroblast cell

line, LM cells, grown in a defined synthetic medium with supplements
of choline or its analogues N,N'-dimethylethanolamine or N-monomethylethanolamine, was able to maintain plasma membrane fluidity constant
by altering the degree of saturation of acyl chains in all classes
of phospholipids.

Only an ethanolamine supplement caused a decrease

in the fluidity of the plasma membrane; again, alterations in the
fatty acid composition of phospholipids was seen (Schroeder, 1978).
This method of supplementation cannot be used to assess any changes
in fluidity but it is a useful means of manipulating membrane lipid
composition and testing for the sensitivity of membrane probes to
changes in their lipid environment (Houslay & Stanley, 1982).
Abnormalities in Cultured Human
Skin Fibroblasts
Owing to its many useful and well defined properties, DPH
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has been used to evaluate membrane fluidity, via fluorescence anisotropy, of a variety of cell membranes.

In particular, it has been

used on cultured human skin fibroblasts from subjects with various
diseases with interesting results.

This information is summarized in

Table 2.
As shown in Table 2, there is decreased polarization value
in fibroblasts obtained from homozygous familial hypercholesterolemia
as compared to controls in both the intact cells and plasma membranes.
It is interesting to note that there is no difference in the polarization values of intact fibroblasts as compared with plasma membranes.
Shaw et al. (1983) have shown that the difference or no difference
observed between the total cell membrane fluidity and plasma membrane
fluidity could be due to the way a plasma membrane is prepared.

They

seem to suggest that the method of membrane preparation is an essential
step in determining membrane fluidity.

Using a sucrose-step gradient,

they have isolated plasma membranes from fibroblasts obtained from
normal subjects as well as fibroblasts from subjects with Duchenne
muscular dystrophy; and on these isolated membranes, membrane fluidity
measurements using DPH revealed an increased fluidity of membranes as
compared to matched controls.

Fluidity in Huntington disease fibro-

blasts has also been evaluated and there is no difference observed
between controls and diseased membranes--either in intact cells, plasma
membranes, microsomes or mitochondrial membranes.

Even though this

technique of determining membrane fluidity has been used only in a
few disease states using cultured human skin fibroblasts, it has a

TABLE 2.--Fluorescence Polarization (25°C) of Cultured Human Skin Fibroblasts from Various Diseases
Fluorescence Polarization
Description of Various
Cell Lines
a. Normal Control
Caucasian (n=2)
Negro (n=4)
b. Homozygous familial
hypercholesterolemia (n=4)
a. Control, 22°c (n=9)
2.
b. Duchenne dystrophy
fibroblasts, 22°c (n=9)
3.*** a. Control (n=lO)
b. Huntington fibroblasts
(n=ll)
4.*** a. Control (n=9,8,8)

Other
Organelles

Intact Cells

Plasma
Membranes

0.242
0.238
0.206

0.242 + 0.013
0.259 + O.Oll
0.208 + O.Oll

Haggerty et al.
(1978)

0.306 + 0.016
0.289 + 0.008

Shaw et al.
(1983)

Ref.

1.

+ 0.003
+ 0.005
+ 0.006

Beverstock &
Pearson 0981)

0.2639 + 0.0085
0.2625 + 0.0179
0.299 + 0.010

b. Huntington fibroblasts
(n=9,8,8)

0.301 + 0.006

Values represent mean + standard deviation.
*microsomes;

**mitochondria;

***mean + standard error of mean.

0.308 + 0.010*
0.266
O.Oll**
0.313
0.007*
0.278
0.012**

+
+
+

Schroeder
(1984)
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very useful potential in investigating inherited metabolic disorders
--especially Gaucher disease.
Lipid Composition of Cultured Human
Skin Fibroblasts
It is important to know the composition of lipids in fibroblasts in order to correlate this with the membrane fluidity measurements.

The amount of neutral lipids have been determined in normal

human cultured skin fibroblasts and the major constituents seem to
be cholesterol, cholesterol esters, and triglycerides.

Some of these

values are summarized in Table 3 (Chatterjee et al., 1976).
Along with neutral lipids, one of the major lipid classes
found in fibroblasts are the glycerophospholipids.

In normal human

fibroblasts, there seem to be several important phospholipids including
sphingomyelin, phosphatidylcholine, phosphatidylinositol, phosphatidylserine, phosphatidylethanolamine, and some disphosphatidylglycerol
and lysophosphatidylcholine (Chatterjee et al., 1976; MalkiewiczWasowicz

et al., 1977; Schroeder et al., 1984).

The results of a

typical phospholipid analysis in cultured fibroblasts is presented
in Table 4 (Schroeder et al., 1984).
Along with neutral lipids and phospholipids, fibroblasts also
contain glycosphingolipids.

Glycosphingolipids make up approximately

3 percent of total membrane lipids (Dawson et al., 1972). Glycosphingolipids can be divided up into neutral glycosphingolipids and
acidic glycosphingolipids (gangliosides).

Neutral glycosphingolipids

in human fibroblasts consist of glucosylceramide (GlcCer), lactosylceramide (LacCer), globotriaosylceramide or trihexosylceramide
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TABLE 3.--Neutral Lipid Composition of Cultured Human
Skin Fibroblasts
Neutral Lipid

µg lipid/mg of Protein

Cholesterol

30

Cholesterol Ester

18

Triglyceride

34

Data adapted from Chatterjee et al. (1976)
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TABLE 4.--Phospholipid Composition of Cultured Human
Skin Fibroblasts
Phospholipid

Composition (mole %)

Phosphatidylcholine

50 + 5

Phosphatidylethanolamine

19 + 3

Phosphatidylinositol +
Phosphatidylserine

10 + 1

Sphingomyelin +
Lysophosphatidylcholine

10 + 1

Cardiolipin

6 + 1

Data adapted from Schroeder et al. (1984). Number of
samples was 4, values represent the mean :t..SEM.
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TABLE 5.--Glycosphingolipid and Ceramide Composition of
Cultured Human Skin Fibroblasts
Glycosphingolipid

nanomol/mg of protein

Neutral
Glycosphingolipid
GlcCer
LacCer
GbOse3Cer
GbOse4Cer

1.11 + 0.48
0.41 + 0.17
2.50 ±. 0.56
1. 40 + o. 29

Gangliosides
GM3
GHz
GM1
GD3
GD1a

3.13
1.10
0.26
o. 71
0.47

Cerami de

Ref.

Saito &
Rosenberg
(1984a)

+ 0.32
+ 0.16
+ 0.03
+ 0.24
+ 0.18
5*

Chen et al.
( 1981)

*Concentration of ceramide expressed as µg/mg of protein.
Values represent the mean ±_SD.
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(GbOse3Cer) and globotetraosylceramide or tetrahexosylceramide
(GbOse4Cer).

Gangliosides in fibroblasts consist of sialosyl lactosyl

ceramide (GM3), sialosyl gangliotriaosyl ceramide (GHz), sialosyl
gangliotetraosyl ceramide (GM1), disialosyl lactosyl ceramide (GD3),
and disialosyl gangliotetraosyl ceramide (GD1a> (Saito

& Rosenberg,

1984a).

Ceramide also

The actual amount is represented in Table 5.

is a constituent of cultured human fibroblasts and it has been determined that its concentration is approximately Sµg ceramide/mg of protein (Chen et al., 1981).
The lipid composition of cultured human fibroblasts may be
altered by a disease process (due to an enzymopathy), such as Gaucher
disease, or it may be altered by culturing the cells in the presence
of chemical modulators.

Monensin, a carboxylic monovalent cationo-

phore, is such a chemical which can modify membrane lipid structure.
It has been shown that monensin decreases activity of lysosomal enzymes
by increasing the pH (Tartakoff, 1983) and may influence glycosphingolipid biosynthesis in the Golgi apparatus (Saito et al., 1984).

Using

monensin, Saito et al. (1984) have shown that there is increased accumulation of the neutral glycosphingolipids GlcCer and LacCer in
normal cultured human skin fibroblasts; and this accumulation is increased in Gaucher diseased fibroblasts which then may be explained
in terms of cation regulation.

At this time, however, the effects

of monensin on neutral lipids, phospholipids, and ceramide is not
known.

CHAPTER III
MATERIALS AND METHODS
Cell Culture
Normal cultured human skin fibroblasts (Human Genetic Mutant
Cell Repository GM 3440 [adult], GM 302A [infant]), type 1 Gaucher
disease fibroblasts (GM 4394 [infant non-neuronopathic]), and type 2
Gaucher disease fibroblasts (GM 877 [infant neuronopathic]) were obtained from the Institute for Medical Research (Camden, N.J.).

Other

fibroblasts were obtained from Dr. David Wenger, University of Colorado
Medical Center, Dr. A Beaudet, Baylor College of Medicine and Dr.
A. Milunsky, E. K. Shriver Center (Waltham, Mass.)--type 1 Gaucher
fibroblasts (AdG 1470, AdG 119a [adult non-neuronopathic]), type 2
Gaucher fibroblasts (InG 1247 [infant neuronopathic]), and type 3
Gaucher fibroblasts (JuvG [juvenile neuronopathic]).

One normal adult

fibroblast cell line was established from biopsy in our laboratory
(NmlF) (Barton & Rosenberg, 1974; Mueller & Rosenberg, 1977; Saito
et al., 1984}.
All cell culture was performed according to well established
methods using 10 ml of growth medium containing 88% Dulbecco's modified
Eagle's medium (GIBCO}, 10% heat inactivated fetal calf serum (GIBCO,
heated at 56°C for 30 min}, and 2% penicillin-streptomycin (5000
I.U. and 5 mg/ml, respectively, Flow Laboratories} in 75-cm2 plastic
46
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tissue culture flasks (Falcon) at 37°C in a 5% C02 atmosphere in air.
Change of media was performed every 5-6 days until the cells were
confluent.

Approximate time for confluency is 10-14 days after seeding

of fibroblasts.

Unless otherwise noted, fibroblasts were between

the fifth and nineteenth passage in this study.

Total cell protein

was determined by the method of Hartree (1972).
Fluorescence Labeling of Cells
The fluorescent hydrocarbon l,6-diphenyl-1,3,5-hexatriene (DPH,
Aldrich) was used as a probe for monitoring the degree of fluidity
of normal and diseased fibroblasts.

Labeling of fibroblast membranes

was done according to the modified procedures of (Shinitzky & Barenholz, 1974; Shinitzky & Inbar, 1974; Fuchs et al., 1975; Haggerty et
al., 1978; Van Hoeven et al., 1979) where 2mM DPH in tetrahydrofuran
was diluted 100-fold with vigorously stirred calcium and magnesium
free phosphate buffered saline (PBS, pH 7.2) and was further stirred
for 30 minutes under a nitrogen stream to evaporate the tetrahydrofuran.

Confluent fibroblasts, in 75 cm2 flasks, were then incubated

with 10 ml of 20µM DPH for 1 hour; whereas, the controls were incubated
with 10 ml of PBS for the same period of time at 37°C.

After incuba-

tion, the cells were detached from the flask substratum, via trypsin
(type III from bovine pancreas, Sigma) treatment (0.05% in PBS for 5
min), and the trypsin activity was neutralized by the growth media.
The cells were recovered by centrifugation (500 xg, 5 min) and suspended in 2 ml of PBS and approximately 50 µl of it was taken to be
counted in a hemocytometer (ultra plane Spotlite counting chamber,
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S/P).

The cells were again centrifuged and resuspended in PBS, using

the appropriate volumes to get the same cell numbers for labeled and
unlabeled cells (: 1-5 x 106 cells/ml).

These were then immediately

used for fluorescence measurements.
For some of these cells, trypan blue exclusion test was also
performed to check the viability of the fibroblasts.

After the label-

ing of cells and collecting the suspension, O.lml of 0.01% trypan
blue in PBS was added to the 1 ml suspension of cells and incubated
for 1-5 min and the cells were counted with a hemocytometer.

The

percentage of viable cells is calculated as:
% viable cells=lOO[l-

no. cells with trypan blue uptake]
total no. cells counted

Fluorescence Anisotropy Measurements
Fluorescence anisotropy and intensity were measured with an
MPF-44B Perkin-Elmer spectrofluorophotometer equipped with Polacoat
polaroid polarizers and a thermostatically controlled cuvette holder
attached to a Fisher Model 90 Refrigerated bath.

Temperature was

maintained by circulating water-methanol (1:1) through the cuvette
chamber.

The excitation wavelength used was 360 nm and emission wave-

length of 426 nm with slits 5 nm each along with a filter cutoff of
390 nm.

Fluorescence polarization (P) and anisotropy Crs)is obtained

from fluorescence measurements via the equations:
I
v,v - I v, h(Ih ,v /Ih , h)
p =
I
+ I h(Ih /Ih h)

v,v

r

s

=

I

v,

,v

,

- 1v 2 h( 1h 2 v 11h 2 h) = 2P
3-P
I
v,v + 21v, h(Ih ,v /Ih , h)
V 2V

where Iv,v is the corrected fluorescence intensity with the polarizers

r
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parallel (excitation and emission polarizers set both at 0°) and Iv h

'

is the corrected fluorescence intensity with the polarizers horizontal
(excitation polarizer set at

o0

and emission polarizer at 90°).

The

factor in parenthesis, Ih,v/Ih,h is the transmission efficiency correction factor of the emission monochromator both parallel and perpendicular to the grooves of the grating.

The corrected fluorescence

intensity was determined by subtracting the intensity of polarized
light measured with unlabeled control cells from the intensity observed
with the labeled cells.

For each of the intensity measurements a 20

second integration is taken.

For each experimental anisotropy, three

independent readings were performed and averaged.
For the different cell lines, anisotropy measurements were
performed at

2s 0 c.

In performing the temperature scan studies, the

initial temperature was 4°C with an incremental increase of 4°C until

40°C was reached.

The temperature was monitored inside the cuvette

with an YSI thermistor probe.
From the fluorescence anisotropy (rs) measurements the apparent
microviscosity (n) with units of Poise was calculated from the express ion

-n = 2.4 rs
o.362 - rs
as shown by Shinitzky and Barenholz (1978) and discussed in Review
of the Related Literature.

The order parameter values were calculated

according to the procedure of Van Blitterswijk et al. (1981):
4
rs
0 28) 112 •
S -- ( 3Q.362-.

For the temperature scans, Arrhenius plots of log rs versus l/tem-
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perature (°K) were performed and analyzed for non-linear break points.
Monensin Treatment and (3H) Acetate
Labeling of Fibroblasts
Confluent fibroblasts (GM 3440, normal adult) were incubated
with 1 µM monensin (in ethanol, Calbiochem) in 10 ml culture medium
for 18 hrs.

Equal volumes of ethanol were added to cells not incubated

with monensin according to Saito et al. (1984).

Along with this,

all the cells were incubated with (3H) sodium acetate (New England
Nuclear, specific activity of 685 mCi/mM).

50.0 µCi was used in 10

ml growth medium.
The amount of lipid was quantitated as described below by
high performance silica gel G thin-layer chromatography (HPTLC).
Radioactivity was determined by scraping each band of interest, transferring the samples into scintillation vials adding 5ml

of Aquasol

(New England Nuclear) and counting in a Beckman LS 1800 Scintillation
Counter.

External standards were established in the scintillation

counter memory to determine the amount of quenching and counting efficiency; thus, from the actual counts per minute (cpm) the disintegration per minute (dpm) are reported.
Lipid Isolation and Quantitation
Confluent cells in 75 cm2 culture flasks were washed with 5
ml cold PBS (4oc, pH 7.2, calcium and magnesium free) three times
and harvested with a home-made rubber policeman.

Total lipids were

then extracted from the cells three times with 2 ml each of chloroform-methanol (2:1, v/v).

The samples were then dried under nitrogen
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(99.99% pure) and redissolved in chloroform and applied to a Unisil
Column (activated silicic acid, 100-200 mesh, Clarkson Chemical Co.,
Pa.).

Unisil column was prepared according to Saito & Rosenberg (1982)

using glass wool in a 5-3/4" length pasteur pipet with silicic acid
added up to 2 cm and pre-washed with chloroform-methanol (2:1, v/v).
Neutral lipids were eluted first from the column with chloroform (3
times with 2 ml) and then phospholipids with methanol (3 times with
2 ml) after redissolving the sample in methanol and reapplying to
the column.

These lipids were then dried under nitrogen (99.99% pure)

and are ready to be quantitated.
The isolated neutral lipids were spotted on a 10 x 20 cm HPTLC
(E. Merck, Darmstadt, Germany) plate along with 5 µl, 10 µl, 15 µl,
and 20 µl of a standard neutral lipid mixture (consisting of 0.4
µg/µ1 cholesterol, 0.06 µg/µl oleic acid, 1 µg/µ1 triglyceride and
0.8 µg/µl cholesterol ester dissolved in dioxane and all chemicals
obtained from Sigma).

The plate was then developed in diethyl ether-

hexane-acetic acid (35:65:2, v/v) until the solvent front ascends to
about 4-5 cm above the bottom edge of the plate.

Following develop-

ment, excess solvent was evaporated in a fume hood for 15 minutes
and then in a vacuum desiccator for 15 minutes.

Then it was rechro-

matographed using diethyl ether-hexane-acetic acid (2:98:1, v/v) until
the solvent front ascends to 1 cm of the top of the HPTLC plate.
After drying the plate·several minutes in air, the lipids
were charred for densitometry with 3% cupric acetate (w/v) in 8% phosphoric acid (v/v) solution and heated at 180°C for 15 minutes (Fewster
et al., 1969) and scanned according to Macala et al. (1983) at 350
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nm (slit

= 0.2

nm, width

=3

nm) in a Kratos model SD 3000 spectro-

densitometer (Kratos, Shoeffel Instrument Corp., N.J.)

attached with

a Hewlett-Packard 3390A integrator (Hewlett-Packard Co., Pa.).

The

scan was done in the "fast" mode on the densitometer along with the
settings on the integrator as follows:

=6
= O.

cm/min, peak width

= 0.04

attenuation

min, threshold

= 5,

= 6,

chart speed

and area rejection

The lipids were then quantitated from comparison with the

standard.

Standard linear plots were determined for cholesterol,

free fatty acid, triglycerides, and cholesterol ester separately as
amount of lipid versus area under the curve and from it, the amount
of sample lipid was determined.
One-fourth the amount of isolated phospholipids were also
spotted on a 10 x 20 cm HPTLC plate along with 5 µl, 10 µl, 15 µl,
and 20 µl of a standard phospholipid mixture (consisting of 2 µg/µl
sphingomyelin, 3 µg/µl phosphatidylcholine, 0.1 µg/µ1 phosphatidyl
serine, 0.05 µg/µl phosphatidylinositol, and 0.5 µg/µl phosphatidyl
ethanolamine dissolved in dioxane and all chemicals obtained from
Sigma). The plate was then developed in chloroform-methanol-water
(60:35:4, v/v) until the solvent front reached to 1 cm from the top
of the plate.

After drying the plate for several minutes in air,

the phospholipids were visualized and quantitated similarly as for
neutral lipids (Macala et al., 1983; Schmitz et al., 1983, 1984; Gopelt

& Resch, 1984).

The scan on the densitometer was

in the "slow" mode

with the settings on the H-P 3390A integrator as follows:

= 6,

chart speed

=2

and area rejection

cm/min, peak width

= O.

= 0.04

attenuation

min, threshold

= 5,
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Initially, to verify that the methanol elution from Unisil
column did indeed give the phospholipids, phospholipids were plated
and then sprayed with the Dittmer-Lester reagent (Dittmer & Lester,
1964) specific for phospholipid, which gave a positive blue spot for
the fibroblast phospholipids.

They were also visualized with iodine

stain to make sure no other lipids were present.

Each phospholipid

was then identified by comparing it with a standard spotted alongside
it and noting the distance migrated.

Each neutral lipid was also

identified by comparing it with a standard.
The yield of the phospholipid and neutral lipid was checked
by densitometry.

For example, the amount of neutral lipid isolated

by chloroform elution from Unisil column was compared against neutral
lipid content in total lipids and the result was approximately 95-99%
of the neutral lipids were recovered, as judged via densitometry.
This was also true for the phospholipids.
Ceramide was also quantitated in cultured human skin f ibroblasts.

The total lipids were isolated as stated previously and dried

under nitrogen.

The lipids were then applied to a Unisil column by

dissolving in chloroform-methanol (9:1, v/v) and eluted three times
with 2 ml of this chloroform-methanol (9:1, v/v) mixture.

This ceramide

containing fraction was then dried under nitrogen and then applied
to a HPTLC plate along with 5 ]J]., 10 ]J]., 15 ]J]., and 20 Ul of standard
ceramide (0.05 ig/]J]. in C-M 2:1) obtained from Sigma (from brain
sphingomyelin) and developed in chloroform-methanol-water (60:25:8,
v/v) until the solvent front reached to approximately 3-3.5 cm from
the bottom edge of the plate according to Selvam and Radin (1981).
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Following development, excess solvent was evaporated in a fume hood
for 15 minutes and then in a vacuum desiccator for 15 minutes.

Then,

it was rechromatographed using chloroform-methanol-acetic acid
(90:2:8, v/v) until the solvent front ascends to 1 cm of the top of
the HPTLC plate.

The percentage recovery of ceramide was estimated

to be approximately 90-95%, as judged by HPTLC plating and densitometry
of the fraction containing chloroform-methanol (9:1) eluant versus
total lipid fraction.

The visualization and quantification of the

ceramide was done exactly as that described for neutral lipids and
phospholipids.

This plate was then scanned with the densitometer in

the "fast" mode with the settings on the H-P 3390A integrator as follows:

attenuation

min, threshold

= 5,

= 6,

chart speed

area rejection

=7

cm/min, peak width

= 0.04

= O.

Fatty Acid Analysis of Phospholipids
and Cholesterol Ester
The phospholipids were isolated as described in the previous
section.

They were then plated onto a 10 x 20 cm plate (prewashed

in the developing solvent system of chloroform-methanol-water [60:35:4,
v/v]) and developed as before.

Afterwards, the plate was air dried

for a few minutes and visualized with iodine.

Appropriate phospho-

lipids were marked along with blank regions and the iodine was evaporated under nitrogen.

It was determined using standard phosphatidyl-

choline that the best way to keep unsaturated fatty acids from being
degraded is to evaporate the iodine immediately with nitrogen, and,
not in a vacuum desiccator.

The marked spots were then scraped and

dissolved in methanol and sonicated for 30 seconds.

The individual
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lipids were then applied to a pasteur pipet, containing glass wool,
and collected in 13 x 100 mm test tubes.

The tubes were centrifuged

to pellet any silica gel that may have been carried through with the
methanol.

The supernatant containing the phospholipid of interest

was then placed into teflon capped 1/2 dram vials (Supelco, Inc.,
Bellefonte, Pa.) and then dried under nitrogen.

The fatty acids were

derivatized to their methyl esters by using either MeOH-HCl (0.5 N,
Supelco) according to Zanetta et al. (1972) or BF3-MeOH (14% w/v,
Supelco) according to Morrison and Smith (1964).
With respect to the MeOH-HCl (0.5 N) as the derivatizing agent,
0.5 ml was added to the teflon capped vials and the vials were flooded
with nitrogen for a few seconds, to replace the air, and the vials
were then tightly capped.

The vials were placed in a Multi-Blok Heater

(Lab-Line Instruments, Inc., Melrose Park, IL) at 100°C for 20 hrs.
After the said period of heating, the vials were cooled to room temperature and the fatty acyl methyl esters were extracted twice with 0.5
ml of hexane.

The hexane was dried and a final volume of 50 µl hexane

was added, and, 5 µl of this was subjected to gas chromatography.
Similar to MeOH-HCl, 0.5 ml of BF3-MeOH was added to the teflon
capped vials and the vials were placed under nitrogen for a few
seconds.

For all phospholipids, except sphingomyelin, the samples

were heated at 100°C for 15 minutes.
were heated at 100°C for 75 min.

Sphingomyelin containing samples

After cooling to room temperature,

the fatty acid methyl esters were extracted twice with 0.5 ml hexane
and dried under nitrogen.

Afterwards, 50 µl of hexane was added, and,

5 µl of this injected into the gas chromatograph.
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The fatty acids of cholesterol esters were examined similar
to that of phospholipids.

Neutral lipids from fibroblasts were ex-

traced as described in the previous section.

These were then spotted

on an HPTLC plate (prewashed in the solvent system of ether-hexaneacetic acid [2:98:1]) and developed as described previously.

After-

wards, the plate was air dried for a few minutes and visualized with
iodine.

The cholesterol ester bands were marked, along with the ap-

propriate blank, and the iodine was evaporated under nitrogen.

The

marked spots were then scraped and dissolved in chloroform and sonicated for 30 seconds.

These then were applied to a pasteur pipet

containing glass wool and collected in 13 x 100 mm tubes.

The tubes

were centrifuged (500 xg, 5 min) to pellet any silica gel that may
have been present after passing through with chloroform.

The super-

natant containing cholesterol ester was placed in a 1/2 dram teflon
capped vial and dried under nitrogen.

Then the fatty acids from cho-

lesterol esters were derivatized with BF3-MeOH (14% w/v, 0.5 ml/vial)
at l00°C for 75 min.

After cooling, the fatty acid methyl esters

were extracted twice with 0.5 ml hexane and dried under nitrogen.

A

final volume of 50 µl was added to the dried lipids, and, 5 µl of
this was injected into the gas chromatograph.
The fatty acid methyl esters were analyzed using a Perkin-Elmer
990 Gas Chromatograph equipped with a flame ionization detector.

The

prepacked column was obtained from Supelco, Inc. containing 5% Ov-210
on Supelcoport.

The conditions used for gas-liquid chromatography

are summarized in Table 6.
The peaks obtained were identified using authentic standards
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TABLE 6.--Conditions for Gas Liquid Chromatography
Using a Perkin-Elmer Model 990 G-C
Condition

Value

Column Temperature:
Initial
90°c
Final
200°c
Temperature Program Rate
4°C/min
Manifold Temperature
200°c
Injector Temperature
240°c
Gas Flow Rates (All gases of Zero Grade)
Hydrogen
30 ml/min
300 ml/min
Air
Nitrogen
7.5 ml/min
5 µl
Sample volume injected
Attenuation
8
fast
Cool Rate
Hewlett Packard 3390A Integrator:
2
Attenuation
0.3 cm/min
Chart Speed
0.04 min
Peak Width
Threshold
1
0
Area Rejection
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obtained from Sigma or Supelco.

The weight percentage of each fatty

acid was determined with respect to an external standard obtained
from Supelco (Supelco Standard F containing 12% C14:0, 4% C16:0, 7%
Cl8:0, 14% C20:0, 25% C22:0, and 47% C24:0).

Cholesterol ester fatty

acids were analyzed with the G-C attached to a Hewlett-Packard integrator, which predetermined the areas; whereas, phospholipid fatty
acids were analyzed with a Fisher Recordall Series 5000 Chart recorder
(0.01 volts, 1 cm/min chart speed) from which the area of each individual peak was obtained by taking the product of height x base at half
height.
Hydrogenation
For an unidentifiable peak in the fatty acids of cholesterol
esters, the fatty acid methyl esters were subjected to platinum reduction using Adam's catalyst (Pt20) according to the method of Christie
(1982).

All of fatty acid methyl esters in hexane, as obtained above,

were taken and dried under nitrogen.

To this sample, 150 µl of meth-

anol (anhydrous) was added along with 1 mg of Adams' catalyst in a
sealed pasteur pipet.

The sample was then placed in a hydrogenation

bottle and connected to a two-way tap reservoir of hydrogen. The sample
was alternatively evacuated and flushed with hydrogen three or four
times to remove any air, and then was vigorously shaken for two hours
at a hydrogen pressure of 21 psi.

After this time, the catalyst turned

black; and the methanol containing reduced fatty acid methyl esters
was transferred to another sealed pasteur pipet and an additional
100 µ1 of methanol was added.

From this, the fatty acid methyl esters
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were extracted twice with 400 µl hexane and placed into teflon capped
vials.

This was then dried under nitrogen and a final volume of 50

µ1 hexane was added, of which, 5 µ1 was injected into the gas chromatograph for identification.

CHAPTER IV
RESULTS
Fluorescence of DPH Incorporation into Cells
A time course study was performed on normal and Gaucher diseased fibroblasts at 25°C and it was noted that the steady-state fluorescence anisotropy value was constant up to the times investigated
(Fig. 7).

The fluorescence intensity was linear up to one hour for

both normal and diseased cells (Fig. 8).

The viability of the cells

was also checked, using the trypan blue exclusion test, and almost
95-99 percent of all the cells were viable up to 1 hr.

In order to

check that the DPH probe was incorporated into the fibroblasts, an
emission spectrum of the labeled and unlabeled cells (excitation wavelength

= 360

nm) was performed for the different cell lines and the

spectra showed the incorporation of probe into the cell membranes
with a relative emission maximum at 426 nm (Figs. 9-15) for the normal
and Gaucher diseased cell lines.

Also, excitation spectra for one

of the cell lines, GM 302A, is shown in Fig. lO(emission wavelength

= 426

nm).

Culture media's intrinsic autofluorescence was also checked

and it was noted there was some probe incorporated into the media
but not to a significant degree that would interfere with the subsequent anisotropy measurements.

It can be noted that the labeled cells
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Fig. 7. Time course study of fluorescence anisotropy of
Normal, NmlF (e),and Gaucher, InG 1247 (O),fibroblasts.
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Fig. 9. Emission spectra of DPH in normal infant fibroblasts
(GM 302A). Curve (a) depicts fibroblasts labeled with DPH and curve (c)
non-labeled cells at the same sensitivity of the fluorometer. Curve (b)
is the same as for (c) except at a higher gain (30x). Excitation
wavelength was 360 nm.
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Fig. 10. Excitation spectra of DPH in normal infant fibroblasts (GH 302A). Emission wavelength was 426 nm.
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Fig. 11. Emission spectra of DPH in type 1 infant Gaucher
fibroblasts (GM 4394). Curve (a) depicts fibroblasts labeled with
DPH and curve (c) non-labeled cells at the same sensitivity of the
fluorometer. Curve (b) is the same as for (c) except at a higher
gain. Excitation wavelength was 360 nm.
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Fig. 12. Emission spectra of DPH in type 2 infant Gaucher
fibroblasts (InG 1247). Curve (a) depicts fibroblasts labeled with
DPH and curve (c) non-labeled cells at the same sensitivity of the
fluorometer. Curve (b) is the same as for (c) except at a higher
gain. Excitation wavelength was 360 nm.
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Fig. 13. Emission spectra of DPH in type 3 juvenile Gaucher
fibroblasts (JuvG). Curve (a) depicts fibroblasts labeled with DPH
and curve (c) non-labeled cells at the same sensitivity of the
fluorometer. Curve (b) is the same as for (c) except at a higher
gain. Excitation wavelength was 360 nm.
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Fig. 14. Emission spectra of DPH in normal adult fibroblasts
(GM 3440). Curve (a) depicts fibroblasts labeled with DPH and curve
(c) non-labeled cells at the same sensitivity of the fluororneter.
Curve (b) is the same as for (c) except at a higher gain. Excitation
wavelength was 360 nm.
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Fig. 15. Emission spectra of DPH in type 1 adult Gaucher fibroblasts (AdG 1470). Curve (a) depicts fibroblasts labeled with DPH and
curve (c) non-labeled cells at the same sensitivity of the fluorometer.
Curve (b) is the same as for (c) except at a higher gain. Excitation
wavelength was 360 nm.
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have greater than 20-30 times the intensity as compared to non-labeled
cells.
Fluorescence Anisotropy of Normal and Diseased Cells
Table 7 shows the steady-state polarization and anisotropy,
measurements for the various cell lines at

2s 0 c.

This

~able

also

has calculated average values for the apparent membrane microviscosity
(n), limiting fluorescence anisotropy (r 00 ) , and the lipid order param-

eter (S) from the steady-state fluorescence anisotropy values as shown
in Materials and Methods, and Review of the Related Literature.

It

can be seen that as compared to normal infant fibroblasts, type 2
and type 3 Gaucher cells had significantly increased anisotropy
values.

Also, from the order parameter and apparent microviscosity,

it can be concluded that there was decreased membrane fluidity for
the neuronopathic (acute and subacute) forms of Gaucher disease.

In

the infant form of type 1 disease investigated, there was no significant difference in anisotropy, and thus membrane fluidity, from normal
cells.

As compared to normal adult fibroblast membranes, type 1

Gaucher cells exhibited a variability of data with respect to anisotropy measurements and thus membrane fluidity.

On the average,

type 1 Gaucher cells exhibit no difference in membrane fluidity as
compared to normal cells; however, for one of the cell lines (AdG
1470), there was significant increase in anisotropy value as compared
to normal cells.

This difference in steady-state fluorescence ani-

sotropy in the various type 1 Gaucher cells could be reflecting the
heterogeneity found among adult non-neuronopathic forms of Gaucher

TABLE 7.--Fluorescence Polarization (P), Anisotropy <rs), Membrane Viscosity (n), Limiting Anisotropy(r00 ) ,
and Order Parameter (S) of Normal and Gaucher Diseased Fibroblasts at 25°C

-n

p

(Poise)

r

00

s

Nml Infant
GM 302A (n=3)

0.251 + .007

0.182 + .006

2.43

0.143

0.628

Type 1 Infant
GM 4394 (n=3)

0.263 + .012

0.192 + .009

2. 71

0.156

0.656

Type 2 Infant
a. InG 1247 (n=5)
b. GM 877 (n=3)

0.303 + .016**
0.311
.019*

+

0.225 + .013**
0.231
.016*

+

3.94
4.23

0.200
0.208

0.743
0.758

Type 3 Juvenile
JuvG (n=3)

0.294 + .006*

0.216 + .005*

3.55

0.188

o. 721

Nml Adult
a. GM 3440 (n=4)
b. NmlF (n=3)

0.270 + .015
0.279
.010

0.198 + .012
0.205 + .008

2.90
3.13

0.164
0.173

0.673
0.692

Type 1 Adult
a. AdG 119a (n=3)
b. AdG 1470 (n=4)

0.262 + .006
0.301
.010***

0.191 + .004
0.223 + .009***

2.68
3.85

0.155
0.197

0.654
0.738

+

+

Each value represents mean + standard deviation, n represents the number of separate determinations.
*P<0.01
**P<0.001 as compared with normal infant
***P<0.01 as compared with normal adult using Student's two-tailed t test.
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disease.

Note, there also existed a difference between the normal

adult and infant cell lines, where there was a significant increase
of fluidity in normal infants as compared to normal adults.
Figures 16 and 17 show the effect of increasing temperature
on fluorescence anisotropy values for normal and diseased cells and
it can be seen, as a general result, that as the temperature increases,
the anisotropy value decreases.

Therefore, the membrane fluidity

increases with increasing temperature for all membranes.

As the first

figure shows, type 2 and type 3 Gaucher cells, which had a significant
difference from normal inf ant cells with respect to anisotropy values
at 2soc, also exhibited a difference in fluidity at all the temperatures.

Each point on the curve represents an average of two different

experiments at the specified temperature.

The determination for type

2 Gaucher cells was done using both the cell lines InG 1247 and GM
877; for type 3 Gaucher cells, the cell line labeled Juv G was used.
This figure then shows that at all temperatures between 4-40°C, there
was decreased fluidity of type 2 and type 3 Gaucher cells.

This con-

clusion also holds true for the type 1 Gaucher cell line (AdG 1470)
which had a significant difference from normal adult cells with respect
to anisotropy value at 2s 0 c.

Therefore, there was decreased membrane

fluidity in type 1 Gaucher fibroblasts at all temperatures between
4-40°C.

From these temperature studies, one can evaluate if there

are any bulk lipid phase transitions by looking at the Arrhenius plots
of log (anisotropy) versus l/temperature.
18 and 19.

This is as shown in figures

Figure 18 shows that there were no identifiable breaks·

in the Arrhenius plots of normal infant fibroblasts, type 2 and type

r
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3 Gaucher cells; thus implying that, between 4-40°C, there were no
bulk lipid phase transitions in fibroblast membranes as judged by
steady-state fluorescence anisotropy using the probe DPH.

d (log
The slope

r

(d (l/T)

8

)
),

as derived from linear least square fit

(Table 8), and the intercept on the ordinate for the Arrhenius curve
for normal infant fibroblasts were different from that of type 2 and
type 3 Gaucher cells.

Figure 19 shows that using normal adult cells

(GM 3440) and type 1 Gaucher cells (AdG 1470) there were no bulk lipid
phase transitions.

Again, the slope and the ordinate intercept were

different in normal adult cells as compared with type 1 Gaucher cells.
Neutral Lipid Content of Normal and
Diseased Cells
Figure 20 shows the HPTLC plate obtained using the separation
system listed in Materials and Methods.

From this, the total amounts

of cholesterol, free fatty acid, triglycerides, and cholesterol ester
were determined.

It is to be noted that once the area was obtained

for each spot for the standard, a standard curve was determined for
total area versus amount of lipid spotted and linear least square
fit was used to determine the best fit, and from it the sample amount
was determined.

A densitometric pattern for one of the lanes is given

in the same figure.
protein.

Each neutral lipid is expressed as

µg/mg of

As can be seen from Table 9, there were no differences be-

tween normal and Gaucher cells with respect to cholesterol and free
fatty acid content.

There was a considerably decreased amount of

cholesterol ester in all three types of Gaucher disease fibroblasts
as compared with normal fibroblasts.

It seems that type 1 Gaucher
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TABLE 8.--Slope, Ordinate Intercept, and Correlation Coefficient
Derived from Arrhenius Plots of Log (Fluorescence Anisotropy)
versus [Temperature (OK)]-1

Cell Type

Slope

Intercept

Corr. Coe ff.

Nml Infant

-2.68

0.0059

0.99

Type 2 Infant

-2.40

0.0051

0.99

Type 3 Juvenile

-2.30

0.0048

0.97

Nml Adult

-2.98

0.0065

0.99

Type 1 Adult

-2.44

0.0052

0.98
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Fig. 20.
fibroblasts.

HPTLC chromatogram of neutral lipids isolated from

(a) Lanes 1-4, 5-20 µl standard neutral lipid mixtures (see Methods).
Lane 5, sample from normal adult fibroblasts (GM 3440). Lane 6,
sample from type 1 adult Gaucher diseased fibroblasts (AdG 1470).
Lane 7, sample from normal infant fibroblasts (GM 302A). Lane 8,
sample from type 1 infant Gaucher diseased fibroblasts (GM 4394).
Symbols used: A, cholesterol; B, free fatty acid; C, triglyceride:
D, cholesterol ester.
(b) Densitometric scan of lane 7 in (a). Symbols defined as above.
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TABLE 9.--Neutral Lipid Composition of Normal and Gaucher Diseased Fibroblasts
Triglycerides

Cholesterol Ester

1.52 + 0.58

35.09 +

4.24

28. 38 +

9.02

29.39 + 12.20

1.07 + 0.69

14.22 +

6.31**

9.46 +

4.94*

Type 2 Infant
a. InG 1247 (n=3)
b. GM 877 (n=3)

35.12 + 19.42
66.12
20. 85

+

1.19 + 1.16
1.64
0.84

+

21. 75 + 16.65
29.64 + 19.44

14.35 + 9.97
10.92 + 11.60

Type 3 Juvenile
JuvG (n=3)

44.66 + 27.52

0.62 + 0.37

32.77 + 15.52

13.13 +

Nml Adult
GM 3440 (n=4)

35.62 + 13.41

0.99 + 0.95

32.04 + 18.07

22.24 + 14.91

Type 1 Adult
a. AdG 119a (n=2)
b. AdG 1470 (n=3)

20.36 - 22.45
37.39 + 23.53

0.16 - 0.18
0.62 + 0.65

9.22 - 12.34
12.20 + 6. 77

Cholesterol

Fatty Acid

Nml Infant
GM 302A (n=3)

39.63 + 15.75

Type 1 Inf ant
GM 4394 (n=3)

Each neutral lipid is expressed as µg/mg of protein.

-

-

-

-

1.91 9. 71 +

-

6.75

3.86
1.89

Each value represents mean ±.. standard deviation.

*P<0.05, **P<0.01 as compared with normal infant using Student's two-tailed t test.
n represents the number of separate determinations.

co

00
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cells had a much more decreased content of cholesterol ester content
as compared to type 2 and type 3 Gaucher fibroblasts.

It is also

interesting to note that only in type 1 Gaucher disease cells there
was also a decrease in the triglyceride content as compared to normal
cells; whereas, both type 2 and type 3 Gaucher cells had triglyceride
content within the normal range.

With respect to the type 1 Gaucher

infant cell line (GM 4394), there was a significant decrease in both
the triglyceride and cholesterol ester content as compared to normal.
Phospholipid Content of Normal and Diseased Cells
Figure 21 shows the HPTLC plate of phospholipids obtained
using the separation system listed in Materials and Methods.

It can

be seen that the major lipids in fibroblasts were sphingomyelin, phosphatidylcholine, phosphatidylserine, phosphatidylinositol, and phosphatidylethanolamine.

From the standards spotted, standard least-

linear curves (total area versus amount of lipid) were determined,
and from it the amount of unknown lipids quantitated.

A densitometric

pattern for one of the lanes is shown in the same figure.

The results

for the phospholipid content for various cell lines are summarized in
Table 10.

As can be seen from this table, there seemed to be no dif-

ference between normal and Gaucher cells with respect to phosphatidylserine, phosphatidylinositol, and phosphatidylethanolamine.

As com-

pared to normal infant cells, type 1 Gaucher infant cells did not
have an altered sphingomyelin content; however, there seemed to be a
trend for decreased phosphatidylcholine content.

Type 2 Gaucher cells

had, on the average, a decreased amount of sphingomyelin and phospha-

90

Fig. 21.
fibroblasts.

HPTLC chomatogram of phospholipids isolated from

(a) Lanes 1-4, 5-20 µl standard phospholipid mixtures (see Methods).
Lanes 5 and 6, samples from normal adult fibroblasts (GM 3440).
Lane 7, sample from normal infant fibroblasts (GM 302A).
Lane 8,
sample from type 1 adult Gaucher diseased fibroblasts (AdG 1470).
Symbols used: A, sphingomyelin; B, phosphatidylcholine; C,
phosphatidylserine; D, phosphatidylinositol; E, phosphatidylethanolamine.
(b) Densitometric scan of lane 7 in (a).

Symbols defined as above.
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TABLE 10.--Phospholipid Composition of Normal and Gaucher Diseased Fibroblasts
PC

SPM
Nml Inf ant
GM 302A (n=3)

101.62 + 32.56

PS

PI

257.37 +

72.00

24.54 + 18.13

7.18 + 1.93

PE

103.5 +

-

62.30

Type 1 Inf ant
GM 4394 (n=3)

90.70 +

6. 71

126.30 +

55.30

10.47 +

2.17

4.46 + 0.60

Type 2 Infant
a. InG 1247 (n=3)
b. GM 877 (n=3)

24.39 +
82.24 +

4.62
8.32

122.93 +
116.47 +

48.82
51.09

11.35 +
12.10 +
-

7.05
6.76

8.04 + 5.75
3.40 + 1.32

Type 3 Juvenile
Juv G (n=3)

43.18 + 21.89

172.60 + 101.62

20.15 +

5.16

5.14 + 2.51

53.79 +

-

16.86

Nml Adult
GM 3440 (n=3)

100.59 + 37.90

212.23 +

13.42 + 14.31

3.47 + 2.32

102.97 +

46.29

Type 1 Adult
a. AdG 119a (n=2)
b. AdG 1470 (n=3)

19.92 - 33.9
108.45 + 70.57

65.5 - 81.6
208.37 + 58.28

12.5 - 21.52
37.46 + 39.98

3.84 - 10.8
10.85 + 7.24
-

33.52

69.31 +
-

18.03

71.87 +
6.33
152.40 + 111.62

-

20.76 - 56.80
128.84 + 45.29

-

Each Phospholipid expressed as µg/mg of protein. Each value represents mean + standard deviation. Control
and Gaucher phospholipid values did not differ significantly by Student's two-tailed t test. Definition
of symbols: SPM, sphingomyelin; PC, phosphatidylcholine; PS, phosphatidylserine; PI, phosphatidylinositol;
PE, phosphatidylethanolamine. n represents the number of separate determinations.
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tidylcholine content as compared to normal infant cells.

In type 3

Gaucher cells, there was no change in phosphatidylcholine content;
however, there seemed to be decreased amounts of sphingomyelin.

It

is interesting to note that the phospholipid content of both normal
adult and normal inf ants were approximately the same.

As compared to

normal adult cell lines, one of the cell lines (AdG 119a) had decreased
amounts of sphingomyelin and phosphatidylcholine; whereas, the AdG
1470 cell line had approximately the same phospholipid composition as
that of normal cells.

This variability in type 1 cells could possibly

be due to the heterogeneity that is found among this disease.
Ceramide Content of Normal and Diseased Cells
Figure 22 shows the HPTLC plate of ceramide obtained using
the separation system listed in the Materials and Methods.

From this

technique, we were able to quantitate the ceramide content of normal
and Gaucher diseased fibroblasts.

It can be seen from Table 11 that

as compared to normal infant cells, types 1, 2, and 3 Gaucher cells
had approximately the same content of ceramide.

This also held true

for type 1 adult Gaucher cells as compared to normal adult fibroblasts.

Ceramide content in cells was 1/10 to 1/50 the concentration

of cholesterol levels.
Effect of Monensin on Normal Fibroblast Lipids
Table 12 shows the effect of monensin on neutral lipids, phospholipids, and ceramide as compared to control cells (methodology
described as previously).

This table describes both the total amounts

of each lipid as well as the counts observed after labeling with (3H)
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Fig. 22. HPTLC chromatogram of ceramide containing lipid
fraction, isolated from fibroblasts. Lanes 1-4, 5-20 ~l standard
ceramide (see Methods). Lane 5, sample from type 1 adult Gaucher
diseased fibroblasts (AdG 1470). Lanes 6-8, samples from type 3
juvenile Gaucher diseased fibroblasts (JuvG). Symbols used: A,
phospholipids; B, ceramide; C, cholesterol; D, cholesterol ester
(migrating with the solvent front).
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TABLE 11.--Ceramide Composition of Normal and Gaucher Diseased
Fibroblasts
Ceramide
Nml Infant
GM 302A (n=3)

2.75 + 1.66

Type 2 Infant
GM 877 (n=3)

1.17 + 0.81

Type 3 Juvenile
JuvG (n=3)

2.73 + 0.49

Nml Adult
GM 3440 (n=3)

0.98 + 0.08

Type 1 Adult
AdG 1470 (n=3)

2.33 + 1.62

Amount of ceramide expressed as µg/mg of protein. Each value represents mean + standard deviation. Control and Gaucher ceramide values
did not differ significantly by Student's two-tailed t test. n represents number of separate determinations.

TABLE 12.--Effect of Monensin on Normal Fibroblast (GM 3440) Lipids
Total Lipid (µg/mg of protein)
M+
Neutral Lipids
Cholesterol
Free Fatty Acids
Triglycerides
Cholesterol Ester
Phospholipids
Sphingomyelin
Phosphatidylcholine
Phosphatidylserine
Phosphatidylinositol
Phosphatidylethanolamine
Ceramide

60.94
2.65
39.55
4.15
65.13
136.23
14.99
5.16
235.33

Radioactivity (dpm/mg of protein)
M+

M-

+ 12.24
+ 0.38
+ 11.26
+ 3.84

14313
10341
61834
482

78.33 + 29.12
+ 6.85
+ 6.67* 224.13 + 44.41
- 1.33** 4.76
+
+ 2.28
+ 0.65
4.83 + 2.56
+ 52.14
247.52 + 67.81

12723
137013
10909
1259
18657

7.42
-++ 0.46*
+
+

3.44
2.18**

0.45 + 0.20

76.67
1. 70
50.64
14.91

0.41 + 0.07

-++ 4004**
799*
+ 12726
111 **
+

-

-++
-+

+
+

3234
7730**
1214**
298*
3074**

44.94 + 17.33

Each value represents mean of three separate trials ±.. standard deviation.
cells; whereas, M- represents non-monensin treated cells.
*P<0.05;

M-

2948
3663
38700
3275

844
-++ 1185

11125
55424
5012
627
7677

+ 2947
+ 13277
-++ 1880
248
- 1716
+

+ 12892
790
+

46.32 + 15.00

M+ represents monensin treated

**P<0.01 as compared with non-monensin treated cells using Student's two-tailed t test.
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acetate for 18 hours in the same cells labeled with either monensin
(in ethanol) or without monensin (but an equal amount of ethanol).
With respect to total lipids, there was a significant decrease
in the amount of cholesterol ester and phosphatidylcholine content
in monensin treated cells. There was significant increase in the free
fatty acid and phosphatidylserine content of monensin treated f ibroblasts.

The amounts of other lipids in monensin treated cells were

comparable to that of non-monensin treated cells.

In relation to

incorporation of (3H) acetate into neutral lipids, there was decreased
incorporation of the label into cholesterol ester; whereas, there
was increased incorporation into cholesterol, free fatty acids, and
triglycerides.

The incorporation of the tritiated label was increased

in phosphatidylcholine, phosphatidylserine, phosphatidylinositol and
phosphatidylethanolamine; whereas, there was no change in sphingomyelin.

Similar to sphingomyelin, ceramide did not have an altered incor-

poration of the label when treated with monensin.

Some of the values

in Table 12 differ from the previous tables since even the controls
are treated with ethanol.
Phospholipid and Cholesterol Ester Fatty
Acid Analysis
The fatty acid methyl esters of individual lipids were determined as described in Materials and Methods.

Table 13 shows the fatty

acid composition of phosphatidylcholine of fibroblasts of normal and
diseased subjects.

As can be seen from this table, the major saturated

fatty acids for phosphatidylcholine were C14:0, C16:0, C18:0, and
C22:0, whereas, the unsaturated fatty acids were mainly C16:1, C18:1,
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TABLE 13.--Fatty Acid Composition of Phosphatidylcholine of Fibroblasts
(Weight %)
Infant

Adult
GM 3440
(Nml)

AdG 1470
(Type 1)

GM 302A
(Nml)

InG 1247
(Type 2)

GM 877
(Type 2)

14:0

1.3

0.8

2.7

3.4

2.7

16:0

24.6

26.4

39.7

25.7

29.6

16:1

4.7

5.8

1. 7

7.8

3.6

18:0

25.3

25.0

26.7

22.9

19.4

18:1

30.9

25.3

16.5

25.8

24.9

18:2

1.3

0.7

0.9

1.9

1.1

18:3

1.3

0.7

1.5

1.6

1.3

20:4

9.8

13.3

9.5

8.3

2.7

22:0

0.8

2.3

0.5

2.4

2.0

24:0

-a

Fatty Acid

aTrace amounts.

10.0
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the same; this was also true for type 2 Gaucher cells (InG 1247) as
compared with normal infants.

In GM 877, type 2 Gaucher cells, there

was increase in amounts of C24:0 as compared to normal cells.
Table 14 shows the fatty acid composition of phosphatidylethanolamine of the various cell lines.

It can be seen in this table
Iii

"I!

that there was increased amount of Cl8:1 in normal adult fibroblast
as compared with type 1 Gaucher cells.

I

Whereas, there was considerable

increased amount of Cl6:0, Cl8:0 and decreased amount of Cl8:1 and
C20:4 in normal cells as compared with type 2 Gaucher cells (InG
1247).

In another type 2 Gaucher cell line, GM 877, there was de-

creased amount of Cl8:1 and decreased amount of Cl8:0 as compared
with normal infant cells.

It should also be noted that the fatty

acid composition of phosphatidylethanolamine was different from that
of phosphatidylcholine.
Table 15 shows the fatty acid composition of sphingomyelin of
the various fibroblastic cell lines.

Type 1 Gaucher fibroblasts

sphingomyelin had a decreased amount of C16:0 and an increased amount
of Cl8:0 and C22:0 as compared to normal adult sphingomyelin fatty
acids.

Sphingomyelin from Type 2 Gaucher fibroblast (InG 1247) had

a considerable increased amount of C16:1 and C24:0 and a decreased
amount of C16:0 and Cl8:0 as compared to normal. In another type 2
Gaucher cell line, GM 877, there was an increase in amount of Cl6:1
and some decrease in C18:0.

It is also to be noted that there was a

difference between normal adult and infant cells with respect to their
sphingomyelin fatty acid content.

And also, the fatty acid composition

I',I
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TABLE 14.--Fatty Acid Composition of Phosphatidylethanolamine of
Fibroblasts
(Weight %)
Infant

Adult

Fatty Acid

GM 3440
(Nml)

AdG 1470
(Type 1)

14:0

-a

16:0

9.3

16:1

0.8

18:0

27.9

36.0

18:1

23.6

14.2

6.6

18:2

GM 302A
(Nml)

38.4

Other
8 Trace

amounts.

43.2

GM 877
(Type 2)

1.9

2.4

19.7

18.0
1.4

2.4

42.6

28.9

32.2

15.5

23.5

30.0

4.5

3.2

1.9

5.2

1.3

9.2

29.5

8.8

6.7

8.3

3.0

18:3
20:4

InG 1247
(Type 2)
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TABLE 15.--Fatty Acid Composition of Sphingomyelin of Fibroblasts
(Weight %)
Inf ant

Adult
GM 3440
(Nml)

AdG 1470
(Type 1)

16:0

52.8

23.7

16:1

2.7

-a

18:0

18.8

42.6

18:1

10.5

4.2

22:0

15.2

29.5

Fatty Acid

24:0
aTrace amounts.

GM 302A
(Nml)

InG 1247
(Type 2)

GM 877
(Type 2)

27.2

49.2

31.3

13.9

18.1

4.4

10.9

13.8

9.8

9.3

19.4

27.4

16.7

48.7
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of sphingomyelin was different from that of phosphatidylcholine and
phosphatidylethanolamine.
Table 16 shows the fatty acid composition of phosphatidylserine
of various fibroblastic cell lines.

It can be seen from the table

that type 1 and type 2 Gaucher fibroblast phosphatidylserine fatty
acids had an increased amount of Cl4:0, Cl6:0, Cl6:1, and Cl8:1 as
compared to normal adult; whereas, there was decreased amounts of
Cl8:0 and C20:4.

Table 17 shows the fatty acid composition of phos-

phatidylinositol and it can be seen that there was an increased amount
of Cl6:0, Cl6:1, and Cl8:1, whereas, there was decreased amount of
Cl4:0 and Cl8:0 in type 2 Gaucher cells.
The fatty acids of cholesterol esters were also analyzed for
normal and Gaucher diseased cell lines.

Table 18 shows that the major

saturated fatty acids for cholesterol ester were Cl4:0, Cl6:0, and
Cl8:0, and the major unsaturated fatty acids were Cl6:1, Cl8:1, Cl8:2,
and Cl8:3.

As compared to normal adult cells, type 1 Gaucher cells

(AdG 1470) had a dramatic increase in the amount of Cl4:0 and a reduction of Cl8:1.

As compared with normal infant cholesterol ester fatty

acid, type 1 infant Gaucher cells had a relative increase in Cl6:0,
and Cl8:1.

Type 2 infant Gaucher cells had an increased amount of

Cl6:0, Cl6:1, Cl8:0 and Cl8:1.

Type 3 juvenile Gaucher cells had an

increased amount of Cl8:1 and Cl8:2.
In Table 18 it is also shown that there was an unidentified
peak in cholesterol ester from normal cell lines which was not observed
in all three types of Gaucher disease.

Hydrogenation on the fatty

acid methyl esters of normal infant cholesterol ester was performed
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TABLE 16.--Fatty Acid Composition of

Phosph~tidylserine

of Fibroblasts

(Weight %)
Infant

Adult

Fatty Acid

GM 3440
(Nml)

14:0

-a

AdG 1470
(Type 1)

GM 302A
(Nml)

InG 1247
(Type 2)

GM 877
(Type 2)

3.2
n.d.b

29.6

18.4

5.8

1.9

11.6

16:0

14.1

16:1
18:0

49.0

32.4

24.7

34.2

18:1

5.0

14.4

25.6

13.5

20:4

45.0

30.1

18.2

22.3

aTrace amounts.
bn.d. denotes not determined.
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TABLE 17.--Fatty Acid Composition of Phosphatidylinositol of
Fibroblasts
(Weight %)
Infant

Adult

Fatty Acid
14:0

GM 3440
(Nml)
-a

16:0

AdG 1470
(Type 1)

GM 302A
(Nml)

n.d.b

19.S
7.0

16:1

InG 1247
(Type 2)

39.6
6.0

18:0

50.0

18:1

2.4

20:4

47.6

aTrace amounts.
bn.d. denotes not determined.

60.2

36.3
4.3

13.2

13.7
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TABLE 18.--Fatty Acid Composition of Cholesterol Ester of Fibroblasts
(Weight %)
Inf ant

Adult
AdG 1470
(Type 1)

GM 302A GM 4394 InG 1247
(Nml) (Type 1) (Type 2)

JuvG
(Type 3)

Fatty
Acid

GM 3440
(Nml)

14:0

1.9

26.7

10.2

15.1

11.9

15.2

16:0

23.5

21.9

16.2

21.3

24.7

11.5

16:1

7.3

1.4

2.4

5.9

7.3

4.3

18:0

16.8

26.3

23.6

21.5

31.3

22.5

18:1

39.4

4.9

10.2

21.5

17.9

21.2

18:2

2.7

9.7

10.7

14.1

6.8

25.2

18:3

2.9

9.2

_a

0.5

Other

6.5

--b

26.7

aTrace amounts.
b

Not detectable.
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to check if this unidentified fatty acid had any double bonds.
genation yielded a peak in the C24:0 region.

Hydro-

Thus, it is most likely

that cholesterol ester of normal fibroblasts have a unique unsaturated
fatty acid, C24 (number of double bonds unidentifiable), which is
not found in Gaucher Disease.
Membrane Fluidity and Correlation with
Various Lipid Ratios
Table 19 shows the cholesterol/phospholipid (mole/mole) and
cholesterol/sphingomyelin (mole/mole) ratio for individual cell lines,
along with the fluorescence anisotropy values.

It can be seen that

there was an increase in the aforementioned lipid ratios of cells
from type 2 and type 3 Gaucher disease, along with significant decrease
in fluidity; whereas, for type 1 infant cells, there was no alteration
in membrane fluidity, along with relatively little change in the relevant lipid ratios.

With respect to normal adult cells, type 1 adult

Gaucher cells exhibited a variability of data with respect to membrane
fluidity as well as the lipid ratios.

In the cell line AdG 119a,

there was no altered membrane fluidity; however, there seemed to be
an increase in cholesterol/phospholipid and cholesterol/sphingomyelin
ratios.

With respect to the cell line AdG 1470, which had an increased

anisotropy (decreased membrane fluidity), there was no increased
cholesterol/phospholipid or cholesterol/sphingomyelin ratio encountered.

Sphingomyelin/phosphatidylcholine as well as sphingomyelin/

phospholipid ratios were also determined and no correlation with the
fluidity measurements could be observed.

It is interesting to note

that even though there was decreased fluidity in normal adult fibro-

TABLE 19.--Fluorescence Anisotropy Values with Relevant Lipid Ratios
rs

C/PL

C/SPM

SPM/PL

SPM/PC

Nml Inf ant
GM 302A

0.182 +

.006

0.164

0.78

0.206

0.395

Type 1 Infant
GM 4394

0.192 +

-

.009

0.166

0.64

0.301

o. 718

Type 2 Infant
a. InG 1247
b. GM 877

0.225 +
0.231 +

.013
.016

0.300
0.361

2.88
1.61

0.102
0.224

0.198
0.706

0.216 +
-

.005

0.300

2.06

0.146

0.250

Nml Adult
a. GM 3440
b. Nml F

0.198 +
0.205 +

.012
• 008

0.164
n.d •

0.70
n.d.

0.232
n.d.

0.474
n.d.

Type 1 Adult
a. AdG 119a
b. AdG 1470

0.191 +
0.223 +

.004
.009

0.260
0.152

1.60
0.68

0.166
0.220

0.373
0.520

Type 3 Juvenile
JuvG

-

Definition of symbols:
C/PL,
SPM/PC,

Cholesterol (mol);
Phospholipid (mol)

C/SPM,

(mol)
SEhingomielin
Phosphatidylcholine (mol)

Each ratio is the ratio of the means.

Cholesterol (mol) ;
Sphingomyelin (mol)

SPM/PL, SEhingomielin (mol)
Phospholipid (mol)
f--'

0
00
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blasts as compared with normal infant fibroblasts, there was no alteration in the cholesterol/phospholipid or cholesterol/sphingomyelin
ratios.

CHAPTER V
DISCUSSION
Relevance of Membrane Fluidity
DPH Incorporation
Cultured human skin fibroblasts have a measurable membrane
fluidity via steady-state fluorescence anisotropy using the fluorescent
hydrocarbon probe DPH.

DPH gets incorporated into fibroblast membranes

and gives characteristic excitation and emission spectra with a relative excitation maximum at 360 nm and emission maximum at 426 nm. The
lipid-probe molar ratio is calculated to be approximately 104-105,
which is well above the range to avoid energy transfer and excimer
formation between probe molecules; this is since Kawato et al. (1977)
have recommended a lipid-probe molar ratio of at least 103 to avoid
these fluorescence phenomenon.

It can also be seen in this study

that fibroblasts have an intrinsic fluorescence which is similar in
all the cell lines (normal and Gaucher) investigated.

The emission

and excitation spectra are similar for both normal and diseased f ibroblasts.

They are also comparable to spectra obtained by other in-

vestigators on fibroblasts as well as other types of cells (Shinitzky

& Inbar, 1974; Van Blitterswijk et al. 1977; Lakowicz & Sheppard,
1981; Schroeder et al., 1984).
It is believed that once DPH gets incorporated into biological
110
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membranes, it aligns itself parallel to the fatty acyl chains in the
middle of the bilayer (Lentz et al., 1976a,b).

In intact cells, the

fluorescent probe gets incorporated not only in plasma membranes,
but also in cytoplasmic membranes.

The exact amount of probe into

each membrane component is not known at this moment.

However, it is

believed that in short term incubation (few minutes), fluorescence
parameters of DPH characterize the plasma membrane; whereas, long
term incubation (up to 90 minutes) characterize both the plasma membrane and intracellular membrane lipid characteristics (Pagano, et
al., 1977; Bouchy et al., 1981).

It is possible to calculate plasma

membrane fluidity in intact cells labeled with DPH by selective quenching, nonradiative energy transfer, of the fluorescence emitted from
the plasma membrane after tagging the cell with an impermeable membrane
electron acceptor such as 2,4,6-trinitrobenzene sulfonate (TNBS) (Grunberger et al., 1982).
Fluorescence Anisotropy
In this study, the objective was to determine the membrane
fluidity of physiological viable Gaucher cells and to compare them
to normal fibroblasts and relate this to the lipid abnormalites which
occur.

As can be seen from Figure 7, the fluorescence anisotropy of

both normal and diseased cells remain relatively constant for the
times investigated implying that once the probe gets incorporated
into the lipid pools, the average distance between the embedded DPH
molecules is high enough to avoid intermolecular transfer of excitation
energy (Shinitzky & Inbar, 1974, 1976).

It also implies that for
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all the times investigated, the compartmentalization of DPH in plasma
membrane as well as the cytoplasmic membranes is approximately the
same in the cell.

It can also be concluded that the probe incorpora-

tion in normal and diseased cells is approximately the same in each
compartment since there is no change in fluorescence anisotropy
measurements with respect to time of incubation of DPH,taking into
account the freely diffusing property of DPH (Shinitzky & Barenholz,
1978).
There are several methods which can be used to measure the
fluorescence anisotropy of intact cells.

One of the ways in which

one can measure the anisotropy of intact cells is to treat the cells
with the fluorei£ent probe and then detach them from the surface of
the flask with EDTA or trypsin (Fuchs et al., 1975; DeLaat, et al.,
1977; Haggerty et al., 1978) and then use the suspension for fluidity
measurements.

It is possible that this may impair the lipid-protein

interactions within the cell membrane.

Therefore, another method

has been set up for cultured cells where fluorescence polarization
can be determined for cells attached to a glass substratum (DeLaat
et al., 1977).

Measurements of neuroblastoma cells with this method-

ology suggest that EDTA and trypsin detachment decrease the apparent
membrane fluidity.

The problem with this type of measurement seems

to be that it does not correct for scattering which might occur due
to the cells on the glass substratum.

In this study, trypsinization

treatment for detaching the cells was chosen since we wanted to compare
the average fluorescence anisotropy of Gaucher fibroblasts with that
of normal cells.

Even though this might give an apparent fluidity
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measurement, it is useful for comparison.

Along with this, it is

suspected that DPH in most biological membranes gives information
regarding lipid-lipid interaction and, thus, trypsin treatment which
destroys lipid-protein interactions may not have a significant effect
on the fluidity measurements (Van Blitterswijk et al., 1977, 1981;
Pottel et al, 1983).
In relation to the discussion above, steady-state fluorescence
measurements were performed on several fibroblastic cell lines from
both normal and Gaucher disease subjects.

At

zs 0 c,

as compared with

normal infant cells (GM 302A), type 1 Gaucher cells (GM 4394) did
not exhibit any difference in the fluorescence anisotropy value; thus,
no change in microviscosity or order parameter was seen. In contrast
to this, type 2 Gaucher cells (InG 1247 and GM 877) and type 3 Gaucher
cells (JuvG) had a significant increase in the fluorescence anisotropy
values and, thus, an increase in the apparent microviscosity as well
as order parameter.

As compared with normal adult fibroblasts, type

1 Gaucher cells exhibited a variability of data.

One of the cell

lines, AdG 119a, did not exhibit any difference in the fluorescence
anisotropy value; whereas, AdG 1470 did have a significantly increased
fluorescence anisotropy value and thus the apparent microviscosity and
order parameter were increased.
Cholesterol/Phospholipid and
Cholesterol/Sphingomyelin Ratios
The decreased fluidity in type 2 and type 3 Gaucher disease
cells also correlated well with the increased cholesterol/phospholipid
and cholesterol/sphingomyelin ratios.

With respect to type 1 infant
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Gaucher cells, there was no altered membrane fluidity as well as no
change in the aforementioned lipid ratios.

This finding of altered

membrane fluidity correlating with altered cholesterol/phospholipid
ratio agrees well with several investigators (Pottel et al., 1983;
Shinitzky & Barenholz, 1978; Owen et al., 1982).

The correlation

of altered membrane fluidity with cholesterol/sphingomyelin ratio
has not been presented previously.

This correlation, however, seems

justified in the sense that Patton (1970) has theoretically proposed
a tight association between cholesterol and sphingomyelin in various
biological membranes.

The tight association between cholesterol and

sphingomyelin has been shown to occur in model membranes (Barenholz

& Thompson, 1980).

Also, Van Blitterswijk et al. (1981) have cor-

related an increased fluidity with a decreased cholesterol/phospholipid ratio and, when this lipid ratio was constant, this was attributed to a decrease in sphingomyelin/total phospholipid ratio.

These

authors have also suggested that cholesterol is the primary important
parameter and sphingomyelin is the secondary important factor determining structural order in biomembranes.

Association of cholesterol

and sphingomyelin also seems important in acanthocytes (which have
decreased fluidity) as shown by Barenholz et al. (1981).

These authors

treated acanthocytes and normal erythrocyte membranes with cholesterol
oxidase and noted that the fluidity of normal and diseased cells was
approximately the same.

This was then interpreted to mean that mem-

brane fluidity is dependent upon normal interactions of cholesterol
with phospholipids (especially sphingomyelin and phosphatidylcholine).
The association between cholesterol/phospholipid and choles-
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terol/ sphingomyelin ratios to membrane fluidity in adult type 1
Gaucher cells did not follow the same pattern as that for the infant
cells.

For one of the cell lines which had no alteration in membrane

fluidity as compared to normal adult cells, there seemed to have been
some increase in the relevant lipid ratios.

Whereas, for the type 1

Gaucher cell line which had a significant increase in the fluorescence
anisotropy measurement, there was no change in the lipid ratios.
could be explained in several ways.

This

One explanation for the cell

line AdG 119a having a constant anisotropy value with an increased
cholesterol/phospholipid ratio could be that these cells have adapted
their lipid concentration and phospholipid fatty acid such as to attain
a "homeoviscous" state.

This homeoviscous adaptation phenomenon has

been observed in murine fibroblasts ( LM cells) where alteration in
phospholipid polar headgroups led to alteration in fatty acid content
of the phospholipids and along with this, no change in membrane fluidity occurred (Schroeder, 1978).
It is useful to note that there was a significant difference
between the steady-state fluorescence anisotropy value between normal
infant fibroblasts and normal adult fibroblasts.

The data presented

in Table 7 show that normal infant fibroblasts had an increased membrane fluidity, since there was a decreased value of fluorescence anisotropy.

The decreased membrane fluidity of aged cells has been

investigated previously in red blood cells by monitoring the electron
paramagnetic resonance spectra of fatty acid spin labels incorporated
into the membranes (Shiga et al., 1979).

In this study by Shiga,

et al., there was decreased membrane fluidity in aged human erythro-
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cytes and it is suggested that this was in part due to lipid/protein
ratio, the modified protein-lipid interaction and/or the influences
of diminished ATP content.
pholipid ratio observed.

There was no change in cholesterol/phosAs another example of decreased membrane

fluidity of aging membranes, Nagy et al. (1983) have shown by electron
spin resonance, using modified stearic acid as a probe of synaptosomal
membranes of rat brain cortex, that there is significantly decreased
fluidity in older rat brain synaptosomes.

Therefore, in this study,

it is not surprising to find decreased fluidity in fibroblast membranes
from adults as compared with normal infant cells.

As can be seen

from Table 19, there was no difference in the lipid ratios for normal
adult and infant cells.

The reason for the altered fluidity could

possibly be altered lipid-protein interactions, amount of ATP changes
(Shiga et al., 1979) or altered fatty acids of phospholipids.

It is

also to be noted that there was no passage effect observed in the
evaluation of membrane fluidity of fibroblasts and is consistent with
the findings of Haggerty et al. (1978).

It is believed that fibro-

blasts have a limited lifetime in culture and they "age" with increasing passage.

However, this "aging" did not contribute significantly

to alter the membrane fluidity (Table 20).
Temperature Scans and Arrhenius Plots
Along with the changes observed in fluorescence anisotropy
and membrane fluidity of different fibroblastic cell lines at

2s 0 c,

temperature studies also revealed the same results as that for 25°C.
As compared with normal infant fibroblasts, type 2 and type 3 Gaucher
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TABLE 20.--Passaging of Fibroblasts and Its Effect on Fluorescence
Anisotropy (rs)
GM 3440 & Nml F
(Nml Adult)
Passage
Number

GM 302A
(Nml Infant)
Passage
Number

13

0.287

17

0.259

14

0.259

18

0.247

14

0.277

19

0.247

17

0.256

33

0.269

34

0.279

37

0.289
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cells had an increased fluorescence anisotropy values between 4-40°C.
For the type 1 adult cell line which had an increased value of anisotropy at 25°C temperature scan study revealed the same phenomena
occurring between 4-40°C.

It is interesting to note that as the

temperature increases, the fluorescence anisotropy decreases--which
agree well with the observation that as the temperature increases,
membrane fluidity increases as well.
From the temperature scans and anisotropy values, Arrhenius
plots (log rs versus I/temperature [°K]) were determined for normal
and diseased cells.

As could be determined from the Arrhenius plots,

there were no phase transitions detectable in either normal or Gaucher
diseased fibroblast membranes.
of Haggerty et al. (1978).

This result is in accordance with that

It is not clear from literature which

type of Arrhenius plots reveal the maximum information--e.g., log
r

rs, log

n,

log P or log (r

0

-1)-l

versus 1/T (Shinitzky & Baren-

holz, 1974; Fuchs et al., 1975; Haggerty et al., 1978; Shinitzky &
Barenholz, 1978; Boitema et al., 1983; Berlin
et al., 1984).

& Sainz, 1984; Nagatomo

In this report, log rs versus 1/T curves were plotted

and no phase transitions could be detected.

Log

n,

log P, and log

r

(r 0 -1)

were also used in the ordinate value for Arrhenius plots

and, again, no phase transitions could be detected.

The possible

reason for not detecting any phase transition, and thus lipid phase
separation could be that DPH gives some average information of the
molecular heterogenous bilayer (Shinitzki

& Barenholz, 1978).

Also,

Ladbroke et al. (1968) have shown that cholesterol diminishes and
eventually abolishes the endothermic lipid phase transition of phos-
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pholipids.

Concentration of 10 mole percentage cholesterol eliminates

the pre-transition of phosphatidylcholines.

In biological membranes,

therefore, cholesterol could be interacting with phospholipid fatty
acyl chains in such a way as to abolish phase transition (Barenholz
et al., 1981).

It also seems worth to note that cholesterol and phos-

pholipids are probably interacting in a similar fashion in both normal
and Gaucher diseased cells such as to give no lipid phase transitions
between 4-40°C.
The differences of slopes in Arrhenius plots of normal from
Gaucher diseased fibroblasts probably implies that the flow activation
energy of lipids in membranes is different (Shinitzky & Barenholz,
1978).

The change in the intercept of normal versus Gaucher cells

reflects the fact that Gaucher cells have an increased microviscosity
at all temperatures between 4-40°C.
As an interesting further study, it would be useful to study
the fluidity of various fibroblast membranes from normal cells and
compare this to membranes from Gaucher fibroblasts.

In particular,

attention must be given to plasma membrane fluidity since much of
the intact cell membrane fluidity arises from these membranes.

Also,

lysosomal membrane fluidity should be discerned since Gaucher disease
is a lysosomal membranous enzymopathy.

Lipid composition of plasma

membranes and lysosomal membranes must also be investigated and correlated with membrane fluidity measurements.

The fluidity measurements

should also be carried out in several related lysosomal enzymopathy
of sphingolipids to determine if there are membrane abnormalities in
these diseases and if any correlations occur.
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Relevance of Neutral Lipid, Phospholipid,
and Ceramide Composition of Fibroblasts
It has been reported by Saito and Rosenberg (1984a) that Gaucher
disease fibroblasts do not have an increased accumulation of glucosylceramide as compared with normal cells (1.23 :!:_0.08 nmole/mg of
protein for Gaucher cells, 1.11
infant cells).

+ 0.48 nmole/mg of protein for normal

However, there is some alteration of higher neutral

glycosphingolipids as well as gangliosides in Gaucher cells.

Until

recently, the quantity of other lipids in Gaucher diseased fibroblasts
(neutral lipids, phospholipids, and ceramide) has not been investigated.

Abnormalities in phospholipid have been suggested by Barton

and Rosenberg (1974) and cholesterol content in one of the cell lines
from Gaucher disease has been determined by Warren et al. (1976) as
discussed previously.
Neutral Lipid Composition
Table 9 shows the neutral lipid analysis for normal and Gaucher
diseased cells.

Neutral lipids were analyzed by high performance

thin-layer chromatography and densitometry.

The developing solvent

system used has not been reported previously and it was able to discern
between cholesterol, free fatty acids, triglycerides, and cholesterol
ester.

From this methodology, the amount of each neutral lipid was

determined.

As compared with normal infant fibroblasts, type 1 Gaucher

cells had significantly decreased values of triglycerides and cholesterol ester; whereas, there was no difference with respect to the
cholesterol and free fatty acid content.

Type 2 inf ant cells had

approximately the same content of cholesterol, free fatty acid, and

12i
triglycerides; whereas, there may have been some decrease in the cholesterol ester content (not statistically significant).

Type 3 cells

had a similar neutral lipid content as that of type 2 fibroblasts.
Normal adult cells did not exhibit any difference, in neutral lipid
content, from normal infant cells.
triglyceride and
adult.

~holesterol

Type 1 adult cells had decreased

ester content as compared to normal

This finding that cholesterol ester may be decreased in all

three types of Gaucher cells, and triglyceride decreased in type 1
Gaucher disease has not been reported previously.

Therefore, even

though there is decrease in activity of only one enzyme (S-glucosidase)
in Gaucher disease which leads to abnormal glycosphingolipid content,
there are other lipid abnormalities which can also occur.

This is

similar to Niemann-Pick disease, type D, in which there is deficiency
of lysosomal sphingomyelinase which leads to increased accumulation
of the phospholipid sphingomyelin in the spleen as well as other
tissues; along with this, cholesterol, cholesterol ester, total phospholipids and bis-(mono-acylglyceryl) phosphate are also increased
above the normal range (Rao & Spence, 1977).
Phospholipid Composition
The major phospholipids in fibroblasts were sphingomyelin,
phosphatidylcholine, phosphatidylserine, phosphatidylinositol and
phosphatidylethanolamine as represented in Table 10.

As compared

with normal infant fibroblasts, there seemed to be somewhat decreased
amounts of phosphatidylcholine in type 1 cells.

Type 2 cells possibly

had both a decreased amount of sphingomyelin and phosphatidylcholine.
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Type 3 cells had on the average, decreased amounts of sphingomyelin.
With respect to normal adult cells, type 1 adult cells exhibited a
variability of data.

AdG 119a seemed to have decreased amounts of

sphingomyelin and phosphatidylcholine; whereas, there was no difference
in the phospholipid content of AdG 1470 as compared with normal adult
cells.
The decrease in sphingomyelin, phosphatidylcholine and cholesterol ester of Gaucher cells could possibly be due to the fact
that since there is deficiency of the lysosomal enzyme S-glucosidase
in Gaucher diseased fibroblasts, there may be a compensatory increase
in the other lysosomal enzymes such as sphingomyelinase, phospholipases
and cholesterol esterase.

It has been suggested by Rappeport and

Ginns (1984) and Besley and Moss (1984) that there is an increase in
activity of lysosomal sphingomyelinase in the cells of patients with
Gaucher disease.

It is also possible that neutral sphingomyelinases

(non-lysosomal) could have an increased activity, thereby, leading
to increased degradation of membrane sphingomyelin.

However, Sutrina

and Chen (1984) have shown that in normal cellular metabolism of plasma
membrane-associated sphingomyelin, majority of it is hydrolyzed by
lysosomal sphingomyelinases and a minor fraction is degraded by nonlysosomal neutral sphingomyelinases.

It'is possible, with respect

to decreased phosphatidylcholine content in Gaucher diseased cells,
that plasma membrane phospholipases could be altered such as to have
increased activity.
phatidylcholine

It is also possible that the synthesis of phos-

in Gaucher cells is inhibited, since there is de-

creased amount of sphingomyelin; and thus, the direct enzyme-mediated
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transfer of phosphorylcholine from sphingomyelin to diglyceride does
not occur (Spence et al., 1983).

The increased activity in cholesterol

esterase could be due to the general compensatory increase in enzymes.
If it is the case that lysosomal sphingomyelinase, phospholipases,
and cholesterol esterase are relatively increased in Gaucher diseased
cells this would then imply that there is a tight association between
S-glucosidase and the aforementioned enzymes.

The fact that there

is also decreased amounts of triglycerides in type 1 Gaucher disease
could be that there is some type of S-glucosidase isozyme deficiency
or a presence of a factor which is stimulating the activity of triglycerol lipase.
Ceramide Composition
The data obtained that the content of ceramide is virtually
the same in normal and Gaucher diseased fibroblasts implies that the
activity of lysosomal ceramidase is probably not altered in diseased
cells. It is also to be noted that the levels of ceramide could be
important in cell homeostasis (Kannagi et al., 1982) similar to cholesterol, and thus a constant level has to be established.

It seems

interesting that ceramide, a precursor to all the glycosphingolipids,
is constant in Gaucher cells; whereas, glycosphingolipids are increased
in Gaucher cells (Saito

& Rosenberg, 1984a).

This constant ceramide

level in Gaucher cells are most likely occurring due to increase synthesis of ceramide from sphingosine and fatty acids.

Thus, even though

the catabolic pathway of glucosylceramide is decreased, the anabolic
starting substrate, ceramide, is tightly controlled.
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Effects of Monesin
The finding that monensin treated normal cells give rise to
decreased cholesterol ester and phosphatidylcholine leads one to suspect that monensin could serve as a chemical modifier which gives
rise to effects similar to Gaucher disease.

This is since monensin

leads to increased glucosylceramide (Saito et al., 1984) and decreased
cholesterol ester and phosphatidylcholine in normal fibroblasts.
These lipid abnormalities do not arise from increased lysosomal enzyme
activities since it is believed that lysosomal functions are inhibited
by monensin by increased pH (Tartakoff, 1983).

It is possible that

the activity of acyl coenzyme A:cholesterol 0-acyltransferase (ACAT),
which catalyzes the formation of cholesterol ester from cholesterol
and fatty acyl coenzyme A (Chang & Doolittle, 1983), is decreased.
This then would lead to decreased cholesterol ester and increased
fatty acids.

The (3H) acetate labeling data agrees well with the

decreased ACAT activity hypothesis.

The increased incorporation of

labeled acetate in cholesterol possibly implies that the activity of
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, which leads
to increased cholesterol synthesis in the cells (Chang, 1983), is
increased.

Also, other lipids had increased label incorporation pos-

sibly due to stimulation of other microsomal enzymes.
In relation to decreased phosphatidylcholine content and increased label in this phospholipid, it is possible that monensin,
which is a cationophore increasing sodium levels in fibroblasts and
possibly calcium levels, increases activity of membrane-bound phospholipases and, thus, increased phospholipid degradation occurs.

This
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is similar to accelerated phospholipid degradation, which occurs in
ischemic liver disease due to increased activity of membrane-bound
phosphalipases activated by Ca2+ increase (Chien et al., 1978).

The

increased incorporation of (3H) acetate label into phospholipids could
be possible ifmonensin induces microsomal enzyme activity.

The pos-

sible reason for increased phosphatidylserine content in monesin
treated cells could be that the activity of microsomal phosphatidylethanolamine serine transferase, which catalyzes a calciwn-dependent
exchange between L-serine and the ethanolamine moiety or phosphatidylethanolamine (Esko & Raetz, 1983), increases considerably.

The rel-

ative stability of ceramide with respect to monesin treatment again
implies that even though glucosylceramide and higher glycosphingolipids
are increased, the starting substrate is highly regulated.
Fatty Acid Composition
Not only are there differences observed in the quantity of
neutral lipids and phospholipids in Gaucher disease, but there are
some differences in the fatty acid components of phospholipids, especially sphingomyelin, and cholesterol ester.

It has been shown by

Kudoh et al. (1983) that i f [stearoyl-1-14c] sphingomyelin is introduced into normal cultured skin fibroblasts, it is degraded in lysosomes to [l4C] stearoyl-sphingosine and [l4C] stearic acid.

This free

fatty acid then enters a fatty acid pool for synthesis of the major
lipids found in cultured skin fibroblasts.

These lipids are identified

to be phospholipids, including phosphatidylcholine and sphingomyelin,
cholesterol ester, ceramide, and the ganglioside GM3 (Kudoh & Wenger,
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1982).

It has been shown by Warren et al. (1976) that Gaucher cells

glucosylceramide fatty acids have an increase in C16:0 and ClB:O and
a decrease in C20:0 and C22:0.

From this, it is possible that cera-

mide, phospholipids, and cholesterol ester in cultured skin fibroblasts
utilize fatty acids from a common pool; and when the pool is depleted,
such as in Gaucher disease where more fatty acid are used up to maintain a normal level of ceramide and an increased quantity of glycosphingolipids, there will be alteration in fatty acid composition of
related lipids.

The association of abnormalities in glycosphingolipid,

sphingomyelin and cholesterol ester fatty acids could be summarized
diagrammatically as follows:
Phospholipids

Tl

1T

Fatty Acid

Sphingosine
\I

Cholesterol~

Cholesterol Ester

'>

Ceramide ( "'
a

1T

Sphingomyelin

). GlcCer(

) Higher
Glycosphingolipids

In normal fibroblasts, glucosylceramide is catabolised in a normal
fashion (pathway a) and thus enough fatty acid is available in the
"pool" for incorporation into other lipids.

However, in contrast,

Gaucher diseased fibroblasts have decreased catabolism of glucosylceramide and thus the fatty acid pool is disturbed, leading to alterations
in glucosylceramide, sphingomyelin, cholesterol ester and phospholipid
fatty acid composition. As a further study, it would therefore be
useful to study fatty acid metabolism in normal and Gaucher diseased
cultured skin fibroblasts.
The finding that the cholesterol ester in Gaucher fibroblasts
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do not have the unsaturated C24 fatty acid implies, again, that the
metabolism of fatty acids is different from that of normal cells.
This fatty acid was not observed by Goldstein et al. (1975) in normal
cultured skin fibroblasts.

The only C24 unsaturated fatty acid in

cholesterol ester has been identified as C24:4 in pork testis by Holman
and Hofstetter (1965).

Thus, it is possible that normal fibroblasts

have the ability to synthesize C24:4; whereas, Gaucher cells cannot
synthesize this polyunsaturated fatty acid.

CHAPTER VI
SUMMARY
Membrane fluidity measurements, via steady-state fluorescence
anisotropy of l,6-diphenyl-1,3,5-hexatriene, were performed on cultured
human skin fibroblasts from normal and hereditary lysosomal S-glucosidase deficient (Gaucher disease) subjects.

At 25°C, type 2 and

type 3 neuronopathic Gaucher diseased fibroblasts displayed decreased
membrane fluidity as compared with normal fibroblasts.
neuronopathic Gaucher cells exhibited variability.

Type 1 non-

Of the three cell

lines with the type 1 (non-neuronopathic) variety of Gaucher disease,
only one had decreased membrane fluidity as compared with normal fibroblasts.

Abnormality in membrane fluidity of the diseased cells was

correlated with an increase in cholesterol/phospholipid and cholesterol/sphingomyelin ratios.
Temperature scan studies of fluorescence anisotropy, between
4-40°C, on normal and Gaucher diseased fibroblasts gave the same results as at 25°C.

From the temperature scans, Arrhenius plots were

constructed to determine bulk lipid phase transitions.

As could be

determined from the Arrhenius plots, there were no phase transitions
detectable over this range in either normal or Gaucher diseased fibroblast membranes.
Neutral lipid, phospholipid and ceramide composition of normal
128
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and Gaucher diseased fibroblasts were determined.

The major neutral

lipids were observed to be cholesterol, free fatty acid, triglyceride
and cholesterol ester.

Types 1, 2 and 3 Gaucher diseased fibroblasts

exhibited a significant decrease in cholesterol ester as compared
with appropriate controls.
content of triglyceride.

Type 1 Gaucher cells also had a lower
Analysis of the fatty acids in cholesterol

esters of normal and Gaucher diseased cells was performed, and it
was determined that there was a major difference between the normal
and the diseased cells.
The major phospholipids of cultured skin fibroblasts were
sphingomyelin, phosphatidylcholine, phosphatidylserine, phosphatidylinositol and phosphatidylethanolamine.

As compared with normal infant

cells, there seemed to be a decreased content of phosphatidylcholine
in type 1 Gaucher cells and, in type 2 Gaucher cells, possibly a decreased amount of sphingomyelin and phosphatidylcholine.

Type 3

Gaucher cells had a remarkably decreased amount of sphingomyelin.
Type 1 adult Gaucher cells exhibited variability.

Fatty acid analysis

of individual phospholipids were also performed, and it was determined
that there was a significant difference in fatty acid composition of
diseased cells--especiallly sphingomyelin.

The content of ceramide

was virtually the same in normal and Gaucher diseased fibroblasts.
Normal cultured skin fibroblasts were treated with the carboxylic monovalent cationophore monensin to determine its effect on
neutral lipid, phospholipid and ceramide composition.

Treatment with

monensin decreased the amount of cholesterol ester and phosphatidylcholine, and increased the content of free fatty acid and phosphatidyl-
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serine.

When the cells were also labeled

with [3H] acetate, there

was increased incorporation of the label into all lipids except into
cholesterol ester, where it was decreased, and sphingomyelin and
ceramide, where the incorporation was relatively constant.

The pattern

due to monensin treatment seems to be similar to that observed in
Gaucher disease.
The findings that membrane fluidity and various lipids, including glycosphingolipids, are altered in Gaucher disease indicates that
even though there is hereditary deficiency of only one lysosomal enzyme, 8-glucosidase, this leads to more generalized membrane effects.
These pronounced metabolic effects are seen in altered membrane fluidity and neutral lipid, phospholipid and fatty acid composition of
Gaucher diseased fibroblasts.
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